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Abstract 
While Papanicolaou (Pap) screening has been implemented since the 1950’s, and is 
linked to decreased rates of cervical cancer, national screening rates are still below the national 
target screening rate. In Contra Costa County (CCC), the current cervical cancer screening rate is 
50.92% (Contra Costa Health Services [CCHS], 2016a). This is far below the national goal of 
93% and the first benchmark of 54.33% needed in order to receive state funding under the 
California Department of Health Care Services (DHCS) Medi-Cal 2020 waiver. The Medi-Cal 
2020 waiver has a 5-year Public Health Incentives and Redesign in Medi-Cal (PRIME) program 
requiring participating health systems to complete projects that improve population health, such 
as increasing cancer screening rates. CCHS needs to increase screening rates in order to receive 
funding from DHCS. 
In this paper, the author of this Doctor of Nursing Practice (DNP) project discusses the 
design and implementation of an evidence-based cervical cancer screening toolkit to increase 
cervical cancer screening rates. The toolkit includes a PowerPoint about the PRIME program and 
cervical cancer screening guidelines for Public Health Clinic Services (PHCS) staff, a pocket 
reference for cervical cancer screening, and a patient handout.  
During the two months following implementation of the toolkit, cervical cancer 
screenings for the PHCS pilot group increased when compared to the same time the prior year. 
The toolkit helped educate providers and patients, meeting the goal of increasing staff and 
patient knowledge about cervical cancer screening. Overall, the toolkit is a cost effective way to 
assist the efforts to increase cervical cancer screening rates and obtain Medi-Cal funding.  
 Keywords: cervical cancer screening, patient education, evidence-based toolkit 
  
INCREASING CERVICAL CANCER SCREENING RATES 3 
Acknowledgments 
 I would like to acknowledge everyone who has supported me throughout my Doctor of 
Nursing Practice (DNP) program. I would like to thank my amazing committee chair, Dr. Prabjot 
Sandhu for guiding me through the DNP process. Thank you to Dr. Nancy Selix for being on my 
committee. You both were there from the very beginning of my FNP education and I could not 
imagine two better people to help me finish this journey. Thank you both for your commitment 
to my education, support, encouragement, and for pushing me to reach my highest potential. 
 I would also like to thank Contra Costa Health Services Public Health Clinic Services for 
allowing me to implement my DNP project. Thank you to Heather Cedermaz, Arlene Lin, 
Michelle Sharman, and Susan Crosby for your continuous support and providing the resources 
needed to complete the project. Thank you to the Public Health Clinic Services staff for your 
support and participation in this project.  
 Finally, I would like to thank my parents and sister for their continued love, support, and 
encouragement throughout my entire educational career. I would not have gotten to this point 
without you.  
  
INCREASING CERVICAL CANCER SCREENING RATES 4 
Table of Contents 
Section I 
 Abstract……………………………………………………………………………………2 
 Acknowledgments…………………………………………………………………………3 
 Table of Contents……………………………………………………………………….…4 
Section II- Introduction……………………………………………………………………….…8 
 Background and Significance………………………………………………...…….…….8 
 Setting……………………………………………………………………………….…...10 
 Local Problem…………………………………………………………………………....11 
 Intended Improvement…………………………………………………………...….…...11 
 Review of the Evidence………………………………………………………………….12 
  Patient Education………………………………………………………………...12 
  Changing guidelines and adherence……………………………………………...13
 Interventions….………………………………………………………………………….16 
 Conceptual Framework………………………………………………………………......17 
  Awareness-to-adherence Model………………………………………………… 17 
  Health Belief Model……………………………………………………………. 18 
  Theory of Planned Change……………………………………….……………... 19 
Section III- Methods ……………………………………………….…………………...……...20 
 Ethical Issues……………………………………………………………………….…...20 
 Pilot Project Setting……………………………………………………………………...21 
 Planning the Intervention………………………………………………………………...21 
  Toolkit Components……………………………………………………………...22 
INCREASING CERVICAL CANCER SCREENING RATES 5 
PowerPoint Presentation…………………………………………………22 
   Pocket Guide……………………………………………………………..22 
   Patient Handout…………………………………………………...……...23 
  Initial Strategy………………………………………………………………........23 
Cost/Benefit Analysis…………………………………………………………….……...24 
Implementation of the Project…………………………………………….……….…….25 
 Statement of the Work……………………………………………………………….......26 
 Time Summary………………………………………………………………...................27 
 Cost Summary………………………………………………………………....................27 
 Methods of Evaluation…………………………………………………………………...28 
 SWOT Analysis……………………………………………………………….................29 
 Return on Investment………………………………………………………………….....30 
 Analysis………………………………………………………………………………......31 
Section IV- Results……………………………………………………………………………...32 
 Cervical Cancer Screening Rates ………………………………………….……………32 
 PowerPoint…………………………………………………………………….….……...33 
Staff practices ……………………………………………………………….…...33 
Scenarios………………………………………………………………………....33 
Evaluation of Toolkit Presentation………………………………………………34 
Pocket Guide………………………………………………………………......................34 
Patient Handout………………………………………………………………..................34 
 CCHS Screening Rates………………………………………………………………......35 
Section V- Discussion………………………………………………………………...................36 
INCREASING CERVICAL CANCER SCREENING RATES 6 
Summary…………………………………………………….…………………………...36 
Relation to Other Evidence………………………………………………………………38 
Barriers and Limitations…………………………………………………………...…….39 
Interpretation…………………………………………………………………………….40 
Section VI- Conclusions………………………………………………………………...............42 
Section VII- Funding………………………………………………………………...................42 
Section VIII- References………………………………………………………………...…...... 43 
Section IX- Appendices………………………………………………………………………...47 
 Appendix A: PRIME Goals……………………………………………………………...47 
 Appendix B: PRIME Program Domains…………………………………………………48 
Appendix C: Letter of Support from Contra Costa Health Services…………………….49 
 Appendix D: Johns Hopkins Nursing Evidence-base Practice Rating Scale…………….50 
Appendix E: Literature Review………………………………………………………….51 
 Appendix F: Awareness-to-adherence Model…………………………………………...52 
Appendix G: Health Belief Model………………………………………………………53 
 Appendix H: Kurt Lewin’s Model of Change…………………………………………...54 
 Appendix I: Statement of Determination………………………………………………. 55 
 Appendix J: Cervical Cancer Screening PowerPoint………………………...…………. 59 
Appendix K: Pocket Guide………………………………………………….…….…….67 
 Appendix L: Patient Handout……………………………………………………………76 
Appendix M: Patient Handout in Spanish ………………………………………………77 
 Appendix N: Cost Benefit Analysis………………………………………………...……78 
Appendix O: Communication Plan………………………………………………………79 
INCREASING CERVICAL CANCER SCREENING RATES 7 
 Appendix P: Pre-Assessment……………………………………………………….……80 
 Appendix Q: Post-Assessment…………………………………………………………...81 
 Appendix R: Work Breakdown Structure…………………………………….…………83 
Appendix S: GANTT Chart……………………………………………………………...84 
 Appendix T: Budget………………………………………………………………….… 85 
Appendix U: Patient Handout Assessment………………………………………………86 
 Appendix V: SWOT Analysis………………………………………………………...…87 
Appendix W: Comparison of PHCS Provider Screening Rates…………………………88 
 Appendix X: Results of Pre and Post PowerPoint Staff Assessments…………………...89 
Appendix Y: Evaluation of PowerPoint Presentations……………………....…….……90 
 Appendix Z: Results of Patient Handout Pre and Post Assessments…………….………91 
 
 
 
 
 
 
  
  
  
INCREASING CERVICAL CANCER SCREENING RATES 8 
Introduction 
Background and Significance 
Since the introduction of the Papanicolaou (Pap) test in the 1950s, the incidence of and 
mortality rates of cervical cancer have decreased significantly in the United States (US). 
(Bernard et al., 2014; Vesco et al., 2011; Moyer, 2012). This is due in large part to introduction 
of the Pap test in the 1950s, its widespread availability and use, demonstrating the importance of 
early, routine, and adequate screening (Vesco et al., 2011). Despite the known benefits of 
cervical cancer screening, most recent updates to guidelines, and widespread availability of the 
Pap test, screening rates remain low. Data from the 2013 National Institutes of Health Survey 
(NIHS) indicates that only 80.7% of women aged 21 to 65 years old report getting a Pap smear 
within the past three years (Sabatino et al., 2015). To ensure optimal screening rates, Healthy 
People 2020 set the target of 93% for women to receive cervical cancer screening according to 
the recommended guidelines (U.S. Department of Health and Human Services, Office of Disease 
Prevention and Health Promotion [DHHS], 2016).  
The Pap test detects early changes in cervical cells that can lead to cancer if left 
untreated. Cervical cancer is one of the slower growing cancers and most commonly diagnosed 
in women ages 35 to 44 (National Cancer Institute [NCI], 2016). Cervical cancers begin with 
preliminary changes to the cervical cells in its early stages. Early precancerous changes of the 
cervix are defined as cervical intraepithelial neoplasias (CIN) and graded in stages, from CIN1 to 
CIN3, with CIN3 being carcinoma in situ, meaning the abnormal cells have not extended beyond 
the tissues of the cervix. The Pap test provides for examination of cervical cells in order to detect 
early abnormal cellular changes, and initiate appropriate treatment before the progression to an 
invasive cervical cancer (Vesco et al., 2011). Since precancerous lesions can be detected easily 
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and accurately with the Pap test and treated early, most deaths from cervical cancer occur in 
women who have not been adequately screened (Moyer, 2012).  
Early detection greatly increases the five-year survival rate for women with cervical 
cancer.  When cervical cancer is diagnosed as localized, meaning it is confined to the part of the 
body where it started, the five-year survival rates is 91.3%. If the cancer spreads to a different 
part of the body it is staged as regional cancer and the 5-year survival rate is reduced to 57.4% 
(NCI, 2016).  Cervical cancer often takes several years to develop, which emphasizes why it is 
so important to identify pre-cancerous cell changes early (American College of Obstetricians and 
Gynecologists [ACOG], 2015). Despite the education regarding the benefits of cervical cancer 
screening, nationwide screening rates remain low (Sabatino et al., 2015). Some possible reasons 
for low screening rates both nationwide and in CCC are lack of adherence to guidelines by 
providers and varying levels of education amongst patients on the importance and benefits of 
cervical cancer screening (Brown, Wilson, Boothe, and Harris, 2011; Nolan et al., 2014; Flores 
& Acton, 2013; Warren &Thomas, 2011)  
Furthermore, in order to receive adequate cervical cancer screening, women must have 
access to the health care system. DHCS helps fund health care services for about 13.3 million 
Medicaid (referred to as Medi-Cal in California) members (California Department of Health 
Care Services [DHCS], 2016a). Medi-Cal waivers are DHCS programs that provide services for 
individuals who may not be eligible under Medicaid rules for insurance coverage (DHCS, 
2016b).  DHCS recently renewed the 5-year Medi-Cal 1115 waiver for 2016 to 2020, which is 
called Medi-Cal 2020. Medi-Cal 2020 has four new programs aimed at improving care. One 
program is the 5-year Public Health Incentives and Redesign in Medi-Cal (PRIME) program. 
PRIME funds are used to remunerate CCHS and other similar safety-net systems for showing 
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improvements in ambulatory care (Walker, 2016). The PRIME program has five main goals and 
every Designated Public Hospital (DPH) wishing to receive funds must complete projects within 
each of three domains: 1) projects that will ensure that patients experience timely access to high-
quality, efficient, and patient-centered care, 2) targeted high-risk or high-cost populations, and 3) 
resource utilization efficiency (Appendices A and B) and achieve specified benchmarks (DHCS, 
2016a; Walker, 2016).  
Setting 
 In May 2016, CCHS initiated efforts to meet a multitude of PRIME program goals in 
order to receive state funding. While there are several improvement goals for PRIME, this 
project aims to meet the PRIME goal of improved cervical cancer screening rates. CCHS 
provides care for more than 180,000 low-income residents of Contra Costa County (CCC). Their 
mission is to “care for and improve the health of all people in [CCC] with special attention to 
those who are most vulnerable to health problems” (CCHS, 2016b). While 13% of CCHS budget 
comes from local tax resources the majority, 87%, is supported by federal and state funding 
programs, like Medicare and Medi-Cal program grants (CCHS, 2016).  After discussions with 
managers of the Public Health Clinic Services (PHCS) division at CCHS, the author was able to 
identify an opportunity to use educational tools to assist the PRIME Cervical Cancer Screening 
team in its efforts to increase CCHS cervical cancer screening rates. The author collaborated 
with the stakeholders, who are the leaders of the PRIME Cancer Screening team, Arlene Lin and 
Heather Cedermaz, and proposed a project that would help CCHS achieve the cervical cancer 
screening PRIME benchmarks. Susan Crosby, Director of Public Health Nursing and PHCS gave 
approval with written support of the author’s project addressing PRIME Domain 1 (Appendix 
C). 
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Local Problem 
CCHS is only screening approximately half the women that it should be. At 50.92%, the 
current screening rate is far below the national goal of 93%. Many patients who receive care 
from CCHS have a large problem list and everything cannot be addressed in one visit. 
Designated Primary Care Providers (PCPs) in the Family and Adult Medicine ambulatory clinics 
frequently refer the patients on their panel to the Women’s Health clinics to get their cervical 
cancer screening. However, the low screening rates suggest that many of these women are not 
getting screened at all. This could be due to a variety of factors: difficulty making an 
appointment, availability of Women’s Health clinics, burden of coming in for an additional 
appointment, lack of understanding about the importance of getting screened, or simply not 
wanting to get the screening done. The CCHS patient population is incredibly diverse and 
provides care for large minority groups, including African Americans, Hispanics, and Asian 
Americans. The diverse patient population indicates the importance of considering the various 
beliefs, barriers, and potential interventions among each ethnic group in order to effectively that 
increase cervical cancer screening rates, especially in minorities (Nardi, Sandhu, & Selix, 2016). 
Intended Improvement 
The aim of this project was to systemically address the efforts of the PRIME Cancer 
Screening initiative to increase the rates of cervical cancer screenings at CCHS in order to 
receive state funding. The first year PRIME benchmark for cervical cancer screening is for 
providers to meet a minimum of 54.33% screening of their patient panel who have accessed care 
at least twice in the past 12 months. Each year of the five-year PRIME program, the goal is to 
increase screening rates by the standard percentage improvement set by DHCS. This is 
considered an “improvement over self” target-setting methodology. DHCS will determine this 
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based on the current screening rate and the available evidence for what is a reasonable 
expectation for clinical change (DHCS, 2016c).  
 In addition to the possible funding from PRIME, adequate cervical cancer screening is 
essential in preventing death, as cervical cancer can be treatable if detected early enough, making 
it critical that CCHS make improvements in the screening rates (NCI, 2016). The cervical cancer 
screening toolkit was proposed as a way to increase staff and patient awareness and knowledge 
about cervical cancer screening and the PRIME program in order to increase screening rates. By 
utilizing the current evidence and screening guidelines to educate staff and patients, CCHS can 
improve cervical cancer screening rates and obtain funding that will allow CCHS to continue 
providing high-quality care to an underserved population.  
Review of the Evidence  
There are many reasons explored and cited in literature that lead to decreased cervical 
cancer screening rates. Many women have a lack of knowledge about cervical cancer and the 
screening process. Additionally, providers also express confusion in regards to the guidelines. 
Research shows that provider training and patient reminders are successful in increasing cervical 
cancer screening. The Johns Hopkins evidence appraisal tool was used to evaluate the strength of 
the literature (Appendices D and E). The literature supports the development of the cervical 
cancer screening toolkit pilot.  
Patient education. The lack of education and knowledge regarding medical procedures, 
screening tests, treatments, and therapies can affect an individual’s compliance and interest in 
seeking care. Brown, Wilson, Boothe, and Harris (2011) discovered that the majority of women 
participating in focus groups had very limited knowledge about cervical cancer. One participant 
stated, “Yeah, I know the name, but I don’t know anything about it” (Brown et al., 2011, p. 722). 
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There is often a lack of understanding about what testing is being done during the pelvic exam, 
with some women thinking the Pap is testing for sexually transmitted infections (STIs) (Nolan et 
al., 2014). Women are also unclear if the Pap test is just for detecting cervical cancer or also 
detects other female cancers, like uterine or ovarian cancer (Bellinger, Millegan, & Abdalla, 
2015). Prior to 2012, multiple organizations had different recommendations for screening 
intervals. The changing guidelines cause confusion for patients, making it unclear when they are 
supposed to get screened and how often (Nolan et al., 2014; Bellinger et al., 2015).   
Moreover, there is inadequate knowledge of the severity of cervical cancer; women did 
not resonate with the message that cervical cancer can kill like breast cancer so they did not 
place as much importance on cervical cancer screening as they do with getting a mammogram 
(Nolan et al., 2014). In contrast, some women believe that cervical cancer is unavoidable. Flores 
and Acton (2013) and Warren and Thomas (2011) discovered that many Hispanic women tend to 
believe that what happens to them is predetermined and cannot be changed, making them less 
likely to have strong health-seeking behaviors like cervical cancer screening. These knowledge 
deficits emphasize the need for better patient education about cervical cancer screening, 
including the implementation of culturally relevant patient education. 
Changing guidelines and adherence.  The United States Preventive Services Task Force 
(USPSTF) updated the cervical cancer screening guidelines in 2012 to reflect the importance of 
cytology and human papilloma virus (HPV) testing. The USPSTF guidelines apply to all women 
with a cervix, without a diagnosis of high-grade precancerous cervical lesion, in utero exposure 
to diethylstilbestrol (DES), or immunocompromised women, such as those with human 
immunodeficiency virus (HIV). Prior to the release of the 2012 guidelines, the USPSTF, 
American Cancer Society (ACS) and American College of Obstetrics and Gynecology (ACOG) 
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had varied screening recommendations. Now, the USPSTF, ACS, and ACOG jointly recommend 
screening with cytology every three years for women 21 to 65 years old. Women 30 to 65 years 
old can be screened every five years if they are screened with cytology and HPV testing. The 
USPSTF does not recommend screening women older than 65 years old if they have had 
adequate screening in the past and are not considered high risk (Moyer, 2012).    
Corbelli et al. (2014) surveyed 316 internists, family physicians, and gynecologists at a 
large academic institution. Thirty-four percent of providers did not adhere the ACOG’s 2009 
guidelines for screening patients under 21 years old, 49% do not adhere to guidelines for age 30 
to 65 years old, and 78% did not adhere to the guidelines for women age 21 to 29 years old. 
Internists were less likely than family physicians or gynecologists to follow the 2009 guidelines 
that recommended less frequent screening. One reason for this may be that internists often refer 
their patients to gynecologists for screening and are less aware of when there are guideline 
changes. One of the big changes in the 2009 guidelines was less frequent screening intervals and 
delaying screening until age 21. Corbelli et al. found that all provider specialties significantly 
over screened women in all age groups. This demonstrates the importance of educating providers 
about the guidelines and the evidence behind the changes.  
Adequate provider knowledge is critical to adherence rates for cervical cancer screening 
guidelines. Teoh et al. (2015) conducted a cross-sectional survey to evaluate provider knowledge 
of the 2012 USPSTF guidelines in addition to self-reported screening practices in a large health 
maintenance organization in Minnesota. The knowledge section had six application questions 
about four patient age groups: less than 21 years old, 21 to 29 years old, 30 to 65 years old, and 
more than 65 years old. The current practices section consisted of 15 questions about each of the 
age categories. There were also questions about their views of how often they adhere to the 
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guidelines and reasons for not adhering. Twelve percent of respondents indicated they were not 
aware of the updated 2012 guidelines. Of those who were aware of the guidelines, 33% learned 
about them from a work e-mail and 51.4% learned about them through their professional 
organization. Approximately 88% of providers indicated they would prefer to learn about the 
guidelines in an e-mail, while 38.7% prefer to have prompts in the electronic health record 
(EHR) system.  
Teoh et al. (2015) found that only 5.7% of providers answered all of the screening 
scenario questions correctly and 79.8% answered four of the 6 questions correctly. The highest 
percentage correct was about screening practices for women with a hysterectomy and no cervix 
(99.2%) and the lowest percentage correct was in the 21 to 29-year-old age group (62.9%). The 
providers self-reported practices revealed that there is low adherence to the guidelines. Seventy-
eight percent reported screening ages 21 to 29 correctly with Pap test only every three years and 
36.7% screened incorrectly with Pap and HPV co-testing in this age group. Eighty-nine percent 
of providers reported accurately screening women ages 30 to 65 years old with Pap test only 
every three years, but only 57.4% correctly screen patients with Pap and HPV co-testing every 
five years. Most providers stated they did not follow the guidelines because they were not aware 
of them. The second most common reason for not following the guideline was that patients 
demand different screening intervals. This study exemplifies the need to increase both staff and 
patient knowledge of screening guidelines and the evidence behind them.  
Prior to the release of concordant guidelines among the different organizations, Han et al. 
(2011) studied provider perceptions of having multiple clinical practice guidelines. More than 
1,200 providers were surveyed about the ACOG, USPSTF, and ACS guidelines. Han et al. found 
that 62% of providers valued having multiple guidelines and favor more aggressive screening 
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rather than conservative guidelines. Although the cervical cancer screening guidelines are now 
concordant, this study exemplifies the confusion and differing practice decisions that exists when 
providers have multiple different guidelines. It is possible that many providers are still following 
the 2009 guidelines that favor more frequent screenings. This demonstrates the need for 
continued education about the evidence behind the current guidelines.  
Interventions. Schwaiger, Aruda, LaCoursiere, Lynch, and Rubin (2013) implemented a 
quality improvement project (QIP) at a university of 30,000 students. A total of 24 providers, 
including physicians, nurse practitioners, and physician assistants, participated in the QIP to 
improve cervical cancer screening rates. In order for providers to effectively integrate new 
guidelines into their current practice, they need to understand the evidence behind the guidelines 
(Schwaiger et al., 2013). The QIP included a nationally accepted computer module about the 
evidence-based science supporting the guidelines and an algorithm for cervical cancer screening 
guidelines. The author also created a pocket guide for each provider for easy reference and use as 
a teaching tool. After implementation of the study, the percentage of patients screened according 
to the guidelines significantly improved from 73.95% to 90.2%. This study demonstrates the 
effectiveness of a multi-faceted educational intervention to increase screening rates.  
Kaczorowski et al. (2013) studied the effect of provider and patient reminders on cancers 
screening rates in Ontario, Canada. Two hundred and thirty-two physicians from 24 different 
primary care networks participated in the study. Electronic medical record data was obtained and 
integrated to form a reminder list for providers of eligible patients who were due or overdue for 
screening. Letters are sent to individual patients to inform them of their health maintenance that 
is due. The letters are sent in the patient’s primary language along with educational materials 
about the preventive service due. Patient reminder letters had approved text that was individually 
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addressed and edited as needed. In addition to the reminder letter, educational materials about the 
screenings needed were sent. The materials were available in multiple languages. One year after 
implementation of the provider and patient reminders, Pap test rates significantly increased from 
68.9% to 75.19%. This study exemplifies the potential increase in screening rates as a result of 
provider and patient reminder letters and education about the recommend screening.  
Conceptual Framework  
 The conceptual framework for this project draws on ideals from various learning and 
behavior change theories such as the awareness-to-adherence model, the Health Belief Model 
(HBM), and Lewin’s theory of Planned Change (TPC), to produce the necessary components of 
the toolkit and make the change in CCHS. The awareness-to-adherence model identifies the four 
steps that physicians and advanced practice providers (APPs) must progress through as they 
work towards complete adherence to new guidelines. The HBM describes six constructs that 
contribute to an individual’s preventive health behaviors. The final framework is Lewin’s Theory 
of Planned Change (TPC). The TPC describes the process of implementing a change in practice.  
 Awareness-to-adherence model. Pathman, Konrad, Freed, Freeman, and Koch (1996) 
propose a theory that simply having the information does not mean providers will change their 
practice. The concept of this model is that there are four steps that providers must go through as 
they move towards adopting new guidelines (Appendix F). Before the guideline is released, the 
providers are considered to be in a state of pre-awareness (Freed, Pathman, Konrad, Freeman, & 
Clark, 1998). The first stage is awareness, which occurs when the guideline is circulated and 
providers learn of the new recommendations. It is important to take into consideration how the 
information is disseminated as this can affect how successful provider awareness is (Freed et al., 
1998). The second step is agreement, when providers understand and approve of the rationale for 
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the guideline (Pathman et al., 1996; Freed et al., 1998). The credibility of the source, benefit of 
the new recommendation, complexity of the new recommendation, and acceptance by medical 
leaders plays a significant role in provider agreement (Freed et al., 1998). Adoption is the third 
step, which occurs when providers start to implement the change into their practice (Pathman et 
al., 1996; Freed et al., 1998). The adoption stage tends to take longer if the recommendation is 
complex or does not fit well with the current practice (Freed, et al., 1998). The fourth and final 
stage is adherence. The provider is considered adherent if the guideline is being consistently 
followed in practice (Pathman et al., 1996; Freed et al., 1998). Failure to progress along the path 
and complete each stage would prevent full adherence to a new guideline, leading to a need for 
creating interventions that will contribute to success at each step (Pathman et al., 1996). At 
CCHS many providers are not aware of or are not adhering to the 2012 guidelines. Some patients 
are due for screening, but the provider does not do it at the visit or testing is done more 
frequently than indicated. CCHS staff members need to learn about the guidelines, the 
importance of adhering to the guidelines in order to meet the PRIME benchmarks, and once they 
do this, they will fully adhere to them.  
 Health belief model. The HBM was created in the 1950s by Hochbaum, Rosenstock, and 
Kegels as a way to explain the psychology that predicts preventive health behavior. The HBM 
has six constructs including: perceived susceptibility, perceived severity, perceived benefits, 
perceived barriers, cues to action, and self-efficacy (Appendix G) (Sharma, 2017). Perceived 
susceptibility is the belief that an individual has about whether they will get a disease or not as a 
result of a particular behavior. Perceived severity is the belief of how much harm will come to 
the individual if they were to acquire the disease. Perceived susceptibility and severity can be 
grouped together to be called the perceived threat. The higher the perceived threat, the more the 
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individual is likely to want to change their behavior to prevent that threat. Perceived benefits 
refers to the belief in the advantages of methods to reduce. Perceived barriers are the beliefs 
about the monetary or and time costs, actual or imagined, of performing the suggested behavior. 
Cues to action are internal or external forces that make an individual feel the need to take action 
which are triggered by understanding of perceived benefits and perceived barriers. The last 
construct is self-efficacy, which is the confidence an individual has in their ability to perform the 
behavior based on the processing of information regarding perceived susceptibility, severity, 
benefits, barriers (Sharma, 2017). This theory is frequently used to promote secondary 
prevention methods, such as screening for diseases, in order to achieve the desired health 
behavior. At CCHS this theory was applied when creating and designing the patient handout and 
educating the patients about the importance of getting screened. The handout provided education 
about cervical cancer and risk factors to address the perceived susceptibility and severity. It also 
provided cues to action to make an appointment and gave them the information needed to make 
the appointment on their own. 
Theory of planned change. Lewin’s TPC has three components: unfreeze, transition, 
and refreeze (Appendix H). According to Shirey (2013), the unfreezing stage entails recognizing 
the problem, conducting a gap analysis, and creating a sense of urgency to motivate the team to 
make the necessary change to close the gap. The transition phase involves creating a detailed 
plan and training that encourages the team to adopt the proposed change. This phase requires 
coaching and clear communication that keep the goal at the forefront with an aim for minimal 
resistance. The third phase of the TPC is refreezing. This is the stabilization of the change so that 
is embedded into the system and can be sustained over time (Shirey, 2013). This is important for 
the project as the author needed to motivate CCHS staff to make the change so they could learn 
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what they needed to do and then put it into practice. The author used the meeting to present 
information about the PRIME initiative and current and target screening rates to unfreeze staff 
thinking about cervical cancer screening. The possibility of losing funding if the benchmark is 
not met, helped create a sense of urgency to make the change. The presentation and 
implementation of the toolkit to unfreeze current thinking. The distribution of the pocket guide 
and patient handout in the clinics helped with the transition phase. The refreezing stage is the 
ultimate goal, but is not complete at this time.  
Methods 
Ethical Issues 
 An overview of the project was submitted to the Doctor of Nursing Practice (DNP) 
faculty for approval. The statement of determination was approved as an evidence-based change 
project and was determined not to be research with human subjects that would require IRB 
approval (Appendix I). No identifying information was recorded from staff or patients. 
The author was guided by the ethical principles of beneficence, non-maleficence, and 
justice while working on this project to help reduce health disparities (American Nurses 
Association, 2016). It is imperative that the patients of this underserved population are treated 
with respect, dignity, and the same high-quality of care as those who are able to afford insurance 
and the high costs of healthcare. The current screening rates in CCC are far below the national 
average. One reason for this may be that the population does not have the same access to care. 
CCHS provides low to no-cost health services, but it is important that patients are still receive 
the appropriate care. CCHS needs to increase efforts to reach out to patients and ensure they are 
receiving adequate screenings.  
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Pilot Project Setting 
 The project was implemented with PHCS, a division of CCHS that provides specialized 
clinics in the ambulatory care setting. The PHCS staff operate Women’s Health, Sexually 
Transmitted Disease, and Homeless Healthcare clinics that are connected to six ambulatory care 
centers throughout CCC. The Homeless Healthcare team also provides homeless outreach in a 
mobile health clinic. This enables them to connect homeless patients to care in the health centers, 
including cervical cancer screening in Women’s Health or Homeless Healthcare clinics.  
 Since PHCS staff work at different locations on a daily basis, all staff members meet on 
the second Wednesday of every month for four hours. The meetings provide an opportunity to 
have all staff together for operations announcements, education and training, and time for each 
staff group to break off for role-specific discussions. During the meetings, staff are able to 
interface with their managers regarding any concerns at the clinics. Since staff members, are 
spread throughout the county on a day-to-day basis, the monthly meeting is the only in-person 
communication where all staff are present. The monthly meeting is a common time where 
everyone is together to receive practice updates or participating in trainings during the meetings. 
That is why the author and the stakeholders decided that the monthly meeting would be the best 
time to present the toolkit to PHCS staff. 
Planning the Intervention 
In order to receive an additional $5 million a year from Medi-Cal for operational funding, 
CCHS is obligated to initiate plans to make system changes that will help them meet the PRIME 
program benchmarks for care. One key domain of focus in the PRIME program is to improve 
overall preventive care services. One of the PRIME project areas was improved cancer 
screenings, which includes cervical, breast, and colorectal cancer. The author worked with the 
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managers of the PHCS division and identified an opportunity to help improve cervical cancer 
screening rates. The cervical cancer screening rates for CCHS are far below the national 
screening goal of 93% and CCHS needs to make yearly improvements in the screening rates in 
order to receive funding. DHCS set the PRIME benchmark for cervical cancer screening to 
increase three percent from the current rate each year.  
Toolkit components. After reviewing the literature and from observations in the clinics, 
the author proposed the cervical cancer screening toolkit: A PowerPoint presentation, pocket 
reference, and patient handout. The purpose was to educate CCHS staff and patients and the plan 
was approved by the PRIME Cancer Screening team leaders.  
PowerPoint presentation. The author created a PowerPoint presentation that could be 
delivered in person and also put on an eLearning system if the pilot was successful. The 
PowerPoint was created for presentation to PHCS staff, which includes providers (physicians 
and APPs), registered nurses (RNs), and community health workers (CHWs) (Appendix J). The 
PowerPoint had six intended outcomes. The first was to gain an understanding of the PRIME 
program and what it means for CCHS and receiving funding. The second and third objectives 
were to learn what the current screening rates for CCHS are and what the PRIME target goal is. 
The fourth objective was to understand the cervical screening tests used and the most recent 
United States Preventive Services Task Force (USPSTF) screening guidelines. The fifth 
objective was to understand the screening follow-up guidelines. The sixth objective was that the 
providers, RNs, and CHWs would gain an understanding of what the PRIME program and effort 
to increase cervical cancer screening means for them and their role in the clinic.  
Pocket guide. The pocket guide was created for use in the clinics as an easily accessible 
reference for staff (Appendix K). The pocket guide contains the 2012 USPSTF cervical cancer 
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screening guidelines and algorithms for follow-up management of abnormal Pap smear results. 
The guide was placed at the nursing station so the staff could use it when determining when the 
patient was due for screening and what follow-up may be necessary if a patient had abnormal 
results. The algorithm for abnormal results was created by the University of Missouri 
Department of Family and Community Medicine (2014) following the 2012 USPSTF guidelines. 
Patient handout. The educational handout for patients was created in order to send 
information about cervical cancer screening with a reminder letter about all health care 
maintenance that is due for the patient (Appendix L). While the initial plan was for the handout 
to be mailed to patients, the author was only able to pilot the handout in the Women’s Health 
clinics. The handouts were placed in the Women’s Health clinics so that all women could have 
access to the information. The nurses also had the handouts available to distribute to patients 
during discharge from appointments for other reasons other than getting a Pap smear. The 
handout was also translated into Spanish, which is the most common primary language of 
patients after English (Appendix M).  
Initial strategy. The initial plan for the project was to pilot the toolkit with the PHCS 
providers, RNs, and CHWs. The PowerPoint was going to be tested at the PHCS monthly 
meeting, the pocket guides were going to be given to all staff members, and the patient handout 
was going to be mailed as a health maintenance reminder letter and also placed in the clinics. 
The purpose of the toolkit was to support the efforts of the PRIME Cancer Screening team to 
increase cervical cancer screening rates in order to receive state funding. Since the PRIME 
program was just starting in May 2016, it was an ideal time for the proposed evidence-based 
change. The PRIME Cancer Screening team leaders were enthusiastic about the proposed project 
and assisted the author in identifying the objectives and key information to be included in the 
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toolkit.  
 The author was expected to lead the effort to create and implement the toolkit. The author 
had previous experience in implementing an evidence-based change project as a Clinical Nurse 
Leader student. As a staff nurse with PHCS, the author was familiar with the clinics and how 
they function on a daily basis. The PRIME Cancer Screening team leaders provided the 
resources to present and print all materials needed for the pilot project.  
The author was also responsible for the evaluation of the project. The author chose to 
evaluate the increase in cervical cancer screening by comparing rates of two months after 
implementation to the same two months the previous year. The author planned to evaluate the 
PowerPoint by administering pre- and post-presentation assessments at the meeting. The 
effectiveness of the pocket guide was going to be evaluated by staff feedback in addition to the 
improved screening rates. The handout was going to be evaluated by asking patients coming in 
for cervical cancer screening if they made the appointment because they received a reminder 
letter and asked questions about screening to see if the handout was effective.  
The author used the agile management method since there were adjustments that needed 
to be made to the project along the way (Spundak, 2014). The author frequently interfaced with 
stakeholders to ensure the project is on track to meet the goal.  The author was ultimately 
responsible for addressing any changes to the plan as the project progressed, but continuously 
collaborated with the stakeholders for final approval.  
Cost/Benefit Analysis 
 Cervical cancer causes significant financial burden in addition to its effect on quality of 
life. There are clear benefits to increasing cervical cancer screening (Appendix N). It is estimated 
that national expenditures for cervical cancer care in 2015 were $1.5 billion (NCI, 2015). The 
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expenditures vary by the phase of care, with more money being spent on initial care and the last 
year of life, and less on continuing care. If abnormalities are detected early and treatment if 
initiated early, it is possible to save the $0.2 billion on continued care and $0.7 billion on the 
final year of life. Additionally, in 2005 it was estimated that there is a loss of productivity of 1.8 
billion dollars in the United States due to cervical cancer deaths (NCI, 2015). In CCHS, a Pap 
test costs $180 and HPV co-testing costs $19.50. These numbers demonstrate that for 
approximately $200, women can be screened for cervical cancer and HPV.  
 Cervical cancer screening also has benefits for quality of life. Women with cervical 
cancer have a lower median age at presentation than many other cancers. Women who receive 
chemotherapy have more symptoms such as sexual dysfunction and urinary and bowel 
dysfunction. Another important indicator of quality of life is self-esteem. Those with low self-
esteem also have higher anxiety and depression rates, which can lead to more treatment costs 
(Chase, Watanabe, & Monk, 2010). These quality of life indicators exemplify the need to screen 
for cervical cancer and detect changes early. By doing so, not only can there be reduced care 
costs, but women can have improved quality of life.  
Implementation of the Project 
The author worked closely with the PRIME Cancer Screening team leaders bi-weekly to 
monitor and evaluate if the overall goal of the project was being met (Appendix O). The author 
monitored the monthly cervical cancer screening rate reports to see if they were increasing and 
meeting the goal of 54.33%. The PHCS nurse manager ran all necessary reports and gave them 
to the author to analyze.  
After creating all the products for the toolkit, the author submitted them to the PRIME 
Cancer Screening team leaders for approval. They leaders approved all products and scheduled 
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the author to present the toolkit at the PHCS monthly meeting in August 2016. At the monthly 
meeting, the author administered assessments before and after the presentation (Appendices P 
and Q). The assessments measured confidence in knowledge of the guidelines and level of 
adherence to them. They also answered five scenario questions to assess their knowledge of the 
guidelines and how to make the decision about when and how to screen. During the presentation 
of the educational module, the author also presented the pocket guide and patient handout that 
were going to be placed in the clinics. The pre- and post-assessments, presentation of the 
PowerPoint, pocket guide, and handout, and question and answer period took approximately one 
hour of the monthly meeting. Staff were interactive during the presentation and appreciative of 
the training. The patient handout and pocket guide were shown on the projector screen. Staff was 
notified that the pocket guides would be available to reference at the nursing station of each 
clinic and also e-mailed to them. After piloting the program with the PHCS staff, the author was 
invited to present the toolkit to ambulatory care staff at other health centers in the county at the 
beginning of 2017.  
Statement of the Work  
 The author was responsible for completing the majority of the work for the project 
(Appendix R).  The initial stages involved a literature review, formation of the DNP committee, 
submitting a statement of determination outlining the project and receiving approval for the 
project from the DNP faculty. In order to plan the project, the author evaluated the evidence to 
ensure the latest evidence-based research is being used to create the toolkit. The author 
developed the project plan, submitted it to the DNP committee and CCHS stakeholders for 
approval. Once it was approved, the author created all the elements of the toolkit: The 
PowerPoint, pocket guide, and patient handout. Once those materials were all approved by the 
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PRIME Cancer Screening team leaders, the author was scheduled to present at the August 2016 
PHCS staff meeting. Following the implementation, the author monitored the cervical cancer 
screening rates for September through October 2016 and compared them to the September 
through October 2015 screening rates.  
Time Summary  
The timeline of the project is demonstrated using a GANTT chart (Appendix S). The 
GANTT chart identified the milestones and expected time of completion in order to help the 
author meet the necessary deadlines for a successful implementation of the project. As changes 
occurred, the GANTT chart was updated to reflect the current work needed for completion. The 
project transpired through a 9-month period, from March 2016 to December 2016. The project 
began in March 2016 after discussions with the nurse managers at CCHS PHCS. The author 
continuously reviewed the literature for evidence-based research related to the topic. The author 
confirmed the Doctor of Nursing Practice (DNP) committee in March and had a change of one 
member in May 2016. A statement of determination that outlines the project was presented to the 
University of San Francisco DNP faculty for approval. The creation of the deliverables and 
implementation of the project took place in July and August 2016. The pilot program was 
delivered to the PHCS providers, RNs, and CHWs at the August 2016 monthly meeting. 
Following the implementation, the rates of cervical cancer screening pre- and post-
implementation were analyzed. The completion of the project with a final presentation to the 
author’s university took place in December 2016.  
Cost Summary 
The project was implemented with a relatively low budget. The total proposed budget 
was $12,747.11 and the actual budget was $10,882,73 (Appendix T). The hourly rate used to 
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calculate the proposed budget was the average rate for each position. The project required 120 
hours of work from the author to assemble the toolkit, implement the project, and evaluate the 
impact of the toolkit on cervical cancer screening rate. The author also spent about 15 hours 
meeting with the various stakeholders throughout the process. The proposed budget was 
calculated based on printing 50 pocket guides and 200 patient handouts and provider time. For 
the final implementation, the author printed 10 pocket guides, one for each health center, and 50 
patient handouts for the pilot project for a total of $129.44. The total cost for one hour of 
provider, RN, and CHW time totaled $1,444.18.   
Methods of Evaluation  
 The evaluation of this DNP project and toolkit consisted of assessing improvements in 
cervical cancer screening rates as well as measuring increases in staff and patient knowledge. 
The first evaluation method were reports obtained from the PHCS nurse manager of the rates of 
screening for September and October 2015. The 2015 rates were compared with the screening 
rates from September and October 2016. The expected outcome was that there would be an 
increase in cervical cancer screening rates following the implementation of the toolkit. This is 
the primary method of evaluation as the overall goal is to increase cervical cancer screening 
rates. One potential problem with this evaluation method is that the provider group in 2015 is not 
the exact same as the provider group in 2016. There are also systems factors, like the availability 
of appointments, and patient accessibility.  
The second method of evaluation examined a change in confidence in using the 
guidelines and knowledge of how to apply them as a result of the PowerPoint presentation 
(Appendices P and Q). The four confidence questions were graded on a 5-point Likert scale, with 
1 being strongly disagree and 5 being strongly agree. The author wrote five scenarios for pre- 
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and post-module assessments. The scenarios addressed knowledge of the guidelines for each age 
group: under age 21 years old, 21 to 29 years old, 30 to 65 years old, over 65 years old, and those 
women with a hysterectomy and no cervix. The pre and post-assessments were the same except 
the post-assessment included feedback questions about the presentation. The author printed and 
handed out the assessments to the staff at the August monthly meeting. The expected outcome 
was that there would be an increase in the average confidence in using the guidelines and an 
increase in the percentage who answered the scenario questions correctly. This method of 
evaluation was created to determine if the PowerPoint was effective in increasing staff 
knowledge of the guidelines, but does not evaluate adherence to them in practice. Another issue 
with the assessment is that it only captures staff knowledge immediately after the presentation 
and does not assess long-term retained knowledge.  
The third method of evaluation was the effectiveness of the handout. This was assessed 
by evaluating patient knowledge of cervical cancer screening before and after receiving the 
patient handout in the clinic. This method changed from the initial plan because the letter was 
not mailed to patients during the pilot project timeframe. The author administered pre- and post-
assessments at randomly selected Women’s Health clinics (Appendix U). The expected outcome 
was that there would be an increase in patient knowledge after reviewing the handout. The 
evaluations were completed by the end of October 2016.  
SWOT Analysis 
 The author conducted an analysis of the strengths, weaknesses, opportunities, and threats 
to the project (Appendix V). There were multiple strengths to the project. One of the main 
strengths is that the author had full support from the stakeholders. The timing of the project 
coincided with the initiation of the PRIME Cancer Screening team’s needs to increase cervical 
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cancer screening rates. Other strengths were the low cost of implementing the project, evidence 
that supports the use of a toolkit, and that the author was able to present to all staff at the PHCS 
meeting. The most important opportunity was the ability to obtain funding from the Medi-Cal 
2020 waiver. Other larger opportunities for the toolkit are improved health outcomes, 
distribution of the toolkit to the entire county, and dissemination of the project at other meetings 
or as an eLearning module centrally hosted that can be reviewed yearly by all CCHS providers.  
Using the DNP student’s model toolkit, other informational toolkits focusing on different areas 
of care within the PRIME initiative can be developed. It is also possible to develop initial 
toolkits for other preventive care measures, specifically colorectal and breast cancer screening.  
 Despite the strengths and opportunities, there were also weakness and threats to the 
project that needed to be considered. Some of the weaknesses were the inability to control how 
many staff members attended the meeting because success of the toolkit would require buy-in 
from all staff. Another issue is that the handout will not reach all patients if it is only available in 
the clinics. Additionally, the initial implementation was only being piloted with the PHCS staff 
and not all of CCHS staff. In order to successfully increase rates to meet the PRIME benchmark, 
the toolkit will need to be distributed to all CCHS staff. One of the main threats to the continued 
success of the project is that the author will not be present following completion of the project to 
continue to update the guidelines; however, it is possible that the author can train an RN to 
update the guidelines and patient handouts as needed. Other threats include a lack of staff 
interest, the possibility that the staff will not utilize the components of the toolkit or put the 
guidelines into practice and that all staff may not complete the training.  
Return on Investment 
The return on investment for this project is substantial, but not realized at this point in the 
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pilot project as the first year of the PRIME program is still in progress. The cost for 
implementing is low with the potential to receive $5 million each year for five years by meeting 
the screening benchmarks. In addition to the direct return on investment, there are indirect 
returns on investment in the improved quality of life for women if abnormalities are detected 
earlier and treated with less invasive procedures. This reduces the financial burden of continuing 
care and end of life cost in addition to limiting the adverse side effects. Although it has not been 
measured at this time or may be difficult to measure, there is a potential cost reduction by 
helping to reduce the number of unnecessary Pap tests and unneeded interventions, such as 
colposcopy. 
Analysis 
The expected outcomes of the intervention were increased cervical cancer screening rates 
and increased staff and patient knowledge of cervical cancer screening. The primary method of 
evaluation was the rate of cervical cancer screening. Overall, for the county, 50.92% of women 
21 to 65 years old and have been seen at least two times in the past 12 months are screened 
according to the guidelines.  Since the pilot program was only done with PHCS staff, the author 
obtained reports of cervical cancer screening rates for only PHCS providers in September and 
October 2015 and compared them to the post-educational module screening rates in September 
and October 2016.  
The second method of evaluation is the level knowledge after completing the educational 
module. The author used a spreadsheet processing program to input and evaluate the pre- and 
post-assessments. The author also analyzed the qualitative responses to the comments section of 
the post-assessment in addition to conversations with staff after the presentation.  
The third method of evaluation is the increase in patient knowledge after receiving the 
handout. The author administered pre- and post-assessments to patients at randomly selected 
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PHCS Women’s Health clinics. The author used a spreadsheet processing program to input and 
evaluate the change in patient knowledge of cervical cancer. Due to the delay in getting approval 
for the handout, the author was only able to gather data from a small sample of English speaking 
patients. The Spanish language handout was not utilized as it had not been approved by 
translation services by the completion of the pilot period.  
Results 
Cervical Cancer Screening Rates  
 The PHCS screening numbers were calculated by adding the total number of screenings 
done by each PHCS provider for each month. In 2015, PHCS providers completed cervical 
cancer screenings in five CCHS health center. There were 11 providers in September 2015 and 
10 in October 2015. In 2016, there were 10 providers in September and 11 providers in October, 
screening patients at six health centers. Overall, the total number of cervical cancer screenings 
completed by PHCS providers in September and October 2016 following the implementation of 
the toolkit increased from the total number of screenings completed in September and October 
2015. However, when comparing each month, there was an increase in screenings in September 
and a decrease in October when compared to the number of screenings in 2015 (Appendix W). In 
September 2015, PHCS providers completed 239 screenings compared to 275 screenings in 
September 2016. PHCS providers completed 274 screenings in October 2015 and 251 in October 
2016. This is likely due to differences in the 2015 and 2016 staff. Other possible reasons are that 
there were more patients scheduling appointments for procedures or other reasons besides 
cervical cancer screening, providers seeing less patients as they train newly hired providers, and 
patients not coming to their scheduled appointments.  
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PowerPoint 
Staff practices. The educational module increased staff knowledge of cervical cancer 
screening guidelines (Appendix X) The pre- and post-assessment data was entered into an Excel 
spreadsheet for analysis. The four confidence questions were graded on a 5-point Likert scale, 
with 1 being strongly disagree and 5 being strongly agree. The results indicate that there were 
increases in staff confidence in determining when the patient is due for screening, what tests they 
need, and that they will be confident in advising the patient when their next screening is due. The 
biggest increase from the pre-assessment was in knowledge about the guidelines, from 3.59 to 
4.39.  
Scenarios. In a pooled survey of 34 staff using the case scenario questions, the results 
from the educational module assessments demonstrated an increase in knowledge for four out of 
the five questions (Appendix X). Nine providers, 14 RNs, and 11 CHWs attended the 
presentation of the toolkit. Scenario question five assessed knowledge about screening patients 
under age 21 and when to start screening patients. Seventy-four percent got this question correct 
before the module and 88.24% got it correct on the post-assessment. Scenario question six 
assessed knowledge of the guidelines for screening women aged 21 to 29 years old. Thirty-three 
percent got this question correct before the module and 60.61% got it correct on the post-
assessment. Scenario question seven assessed knowledge about the screening options for women 
ages 30 to 65 years old. This was the question that showed a decrease in the percent who got it 
correct, from 37.04% to 29.41%. This question had two correct options and many only chose the 
most effective screening method according to the guidelines; however, 88.9% correctly answered 
the primary recommendation of Pap test with HPV testing on the post-assessment. Scenario 
question eight assessed knowledge about the screening for women over age 65 and when to stop 
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screening. Seventy-four percent got the question correct before the module a positive increased 
to 91.18% correct was seen on the post-assessment. Scenario question nine evaluated knowledge 
of screening guidelines for women with a hysterectomy when the cervix was removed and there 
is no history of cervical cancer or dysplasia. Eighty-five percent got this question correct before 
the module and 97.06% got it correct on the post-assessment. Overall, the assessments indicate 
that knowledge was increased after the educational module.  
Evaluation of toolkit presentation. The presentation of the toolkit (Appendix Y) was 
well-received by the staff. Staff members were engaged and asked a lot of questions during the 
presentation. One staff member wrote, “as a new Community Health Worker, I learned a lot. 
Great presentation.” Another wrote, “I never knew about the 5-year guideline, thanks.” One of 
the providers wrote, “that was super helpful. I need that information.” One suggestion was that it 
would have been helpful to have a handout with the guidelines during the presentation.  
Pocket Guide 
The pocket guide was well-received by all staff. One RN stated, “We really needed this 
since there is always some confusion about what needs to be done.” Overall, all staff members 
saw it as useful resource to have available in the clinic. 
Patient Handout 
 The patient handout was effective in increasing patient knowledge of cervical cancer 
screening (Appendix Z). After obtaining consent from the patient, the author asked the pre-
handout questions and then gave the patient the handout while they were waiting for the 
provider. At the end of the visit, the author asked the patient the post-handout questions. Despite 
the small sample size of only 10 patients, the handout showed increases in knowledge about the 
Pap test and HPV in addition to the screening guidelines. The average age of the patients 
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surveyed was 41.13 years old. Half of the patients screened were coming in to the clinic 
specifically for a Pap test, while the other half had various different visit reasons. The most 
frequent reason stated for making the appointment was that they had not had one in years. One 
patient stated, “I haven’t had one in years, so I just figured I should come in.” Other reasons for 
making a Pap appointment were that their gynecologist told them to or someone called to make 
them a Pap test appointment.  
 Before the handout patient handout, 62.5% of patients had heard of the HPV vaccine, but 
only 37.5% knew that it was a risk factor for developing cervical cancer. After the intervention 
62.5% correctly identified HPV as the main risk factor for developing cervical cancer. The 
patient handout increased knowledge of Pap test only screening intervals of every three years 
from 37.5% answering correctly to 75%. None of the patients knew about the five year screening 
interval with the Pap and HPV co-test and 75% knew the correct interval after reading the 
handout. Finally, 12.5% of patients knew that screening stopped at age 65 years old if there was 
no history of abnormal results in the past 20 years and all patients answered it correctly on the 
post-assessment.  
 Patients also answered a question about how they were screened, after receiving the 
handout and completing their cervical cancer screening visit. None of the patients knew exactly 
how they had been screened, specifically what tests had been done. Two patients stated, “she 
didn’t tell me” while two other simply said they did not know. Another patient knew some of the 
tests that were done: “Pap gonorrhea, and something else, but I forgot.”  
 CCHS screening rates. CCHS initiated its efforts to meet the PRIME cervical cancer 
screening goal of 54.33% at the end of May 2016. The cervical cancer screening rate in May 
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2016 was 51.15%. In September and October 2016, the screening rates increased to 52.32% and 
52.59%, respectively.  
Discussion 
 Summary 
The pilot implementation of the toolkit over just a 4-month period was successful in 
increasing cervical cancer screening rates for PHCS and educating staff and patients about 
cervical cancer screening. The success of this pilot program demonstrates the potential to impact 
the screening rates and help CCHS achieve the benchmarks needed to obtain PRIME funding if 
adequately sustained and enforced or even conducted for a longer period of time. The toolkit is 
of value to primary clinical practice because it is a way to ensure all staff members have the 
same information and are working towards a common goal of increasing screening rates.  
 One of the key findings from the staff and patient assessments is that there are significant 
knowledge deficits. After the PowerPoint presentation, staff knowledge of guidelines and 
confidence in using them increased. Many of the newer employees thought the information was 
extremely useful because they were not aware of it. This identifies that there would be a benefit 
to having all newly hired employees review the toolkit materials as part of the onboarding 
process. It would also be useful to send out occasional reminder e-mails to all staff and if any 
updates to the guidelines are released or provide educational modules at quarterly meetings.  
The patient handout also helped increase patient knowledge of screening.  The patient 
survey was incredibly useful for identifying the common misconceptions, knowledge deficits, 
and possible reasons for the low screening rates. The patients that mentioned that they did not 
know how they were screened because the provider had not told them highlights the need for 
improved staff-patient communication during the visit. It may be beneficial going forward for all 
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members of the team to make sure the patient is aware of exactly what tests are being done. The 
CHW can be specific about what tests the patient will need based on the guidelines as they room 
the patient, then the provider can provide education about what the Pap test and HPV test are for 
in more detail during the visit, and finally, the RN can answer any further questions about what 
testing was done. During discharge, the RN can make sure to let the patient know exactly what 
tests were done and when the next screening will be due if everything is normal. They can also 
use a technique of providing the handout while the patient is waiting prior to the exam to prepare 
them and also allow them to ask questions of their provider as was done during the pilot of the 
handout. 
The overall increase in cervical cancer screening rates for CCHS and not just for PHCS 
providers where the toolkit was piloted indicate that the toolkit was not the only reason for the 
increase in screenings from May 2016 through October 2016. However, it can still be a valuable 
tool to help increase rates even further if all county staff members are trained and have the 
toolkit resources available. Other reasons for the overall CCHS screening rates increase were that 
the PRIME Cancer Screening team was sending reminders to providers about the PRIME goals 
and current screening rates, staff members were calling patients who were due for screening to 
schedule appointments, and staff were combing charts to see which patients on the schedule were 
due for screening, regardless of whether or not that was the reason they made the appointment. 
The toolkit would be a beneficial way to bolster the efforts to increase cervical cancer screening 
rates system wide in order to receive $5 million a year in PRIME funding.  
The PowerPoint seemed to be the most effective part of the pilot project. It provided an 
opportunity to discuss the PRIME program and its importance for obtaining funding with all 
staff. Additionally, the PowerPoint was helpful in making all staff members aware of the 
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guidelines. The pocket guide helped supplement what staff learned during the presentation 
because there is a quick reference for what needs to be done in the clinic.  
 	 In order to sustain these changes in screening rates at CCHS, there needs to be more 
education for staff and patients. Staff will need frequent updates and reminders about the most 
current guidelines. Additionally, the PRIME Cancer Screening team may need to evaluate the 
best way to educate patients and reach patients that are not already scheduled for appointments. 
Simply having the handout in the clinics or even mailed out does not guarantee that they will 
read the handout or understand everything it says. 	
After the successful implementation of the cervical cancer screening toolkit, the author 
was invited to present to the staff at a monthly meeting at another health center. The plan for 
further dissemination is that the author will continue to present at staff meetings over the next 
few months. There is also discussion about eventually putting the educational module on an 
eLearning system and requiring yearly review for all CCHS providers, RNs, and CHWs.  
Relation to Other Evidence 
The results of this DNP project are similar to the findings of previous studies. Similar to 
what Bellinger et al. (2015), Nolan et al. (2014) and Brown et al. (2011) suggested, the patient 
surveys indicated that patients have limited knowledge about cervical cancer, HPV as a risk 
factor, and what is done for screening. The pre- and post- PowerPoint presentation assessments 
revealed similar findings to the studies of provider adherence to guidelines (Teoh et al., 2015; 
Corbelli et al., 2014). 
The toolkit was useful in increasing staff knowledge with a PowerPoint presentation and 
pocket guide just as Schwaiger et al. (2013) found in their study. The patient handout was 
developed because of evidence of the effectiveness of a patient handout in increasing screening 
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rates, as demonstrated in the Kaczorowski et al. (2013) study. Though the handout was not 
mailed during the pilot phase, the increase in patient knowledge after receiving the handout and 
the literature supporting the use of mailed handouts indicate that it would be beneficial to CCHS 
efforts to increase screening rates.   
Barriers and Limitations 
With any project there are barriers, both potential and realized, that must be addressed in 
order for implementation to be successful. There were a few potential barriers to implementation 
of the toolkit. One concern was getting complete buy-in from the stakeholders. The stakeholders 
for this project were the leaders of the PRIME Cancer Screening project for CCHS and the 
members of the care team who the project is being designed for. The goal of the project was to 
increase cancer screening rates, but all stakeholders may not have believed that an educational 
module is necessary. The author addressed this barrier with clear communication about the low 
screening rates for providers, explaining the involvement of the entire care team, and the tools 
for patient education. However, the author received positive feedback from all members of the 
care team. The providers had a slightly lower average score about the usefulness of the toolkit 
for their practice, but it was still an agreement that it was useful.  
Many of the providers may not want to participate because they believe they are already 
aware of the guidelines and practicing correctly. They may also be resistant to having to listen to 
another educational presentation. Additionally, other staff members may not understand why 
they need to learn about the guidelines. The author emphasized the importance of having the 
whole care team on board in order to provide the best preventive care for the patients in addition 
by informing the members of the care team about current screening rates and goals.  
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 There were also barriers with the educational handout for patients. The initial plan was 
that the handout would be sent with a reminder letter about health care maintenance that is due. 
One barrier here is that many patients do not have a permanent residence so they may not receive 
the letter. The author addressed this by having the handouts available in the clinics. However, at 
the time of the pilot project, the letter was not yet used for mailing, and the Spanish language 
handout was not approved by the translation department for use. Despite this change in the 
implementation plan, the author was able to pilot the handouts with a small sample of English 
speaking patients in the clinics. This may have provoked limitations to actual results since the 
handout was a key piece to reaching patients and involving them actively in making follow up 
appointments for screening.  
 One limitation to the pilot program was that not all PHCS staff members were present at 
the meeting. Thirty-four of the 65 PHCS staff members were in attendance at the presentation; 
however, the module was emailed to all PHCS staff members for review and the pocket guide 
was available for all staff at the clinics. Another issue was that there was some confusion 
regarding the guidelines and the current screening practices at CCHS. During the presentation, 
one of the providers mentioned that CCHS screens for HPV starting at age 25. The PRIME 
Cancer Screening team leader was able to address the discrepancy, but it may have led to 
confusion when completing the assessments, specifically question six about how to screening a 
26-year-old patient. The author addressed this issue by following up on the CCHS policy and 
guideline at the September meeting. CCHS policy is that providers screen patients age 25 to 29 
years old with cytology and reflex HPV testing is done if the cytology is abnormal. 
Interpretation 
 The anticipated outcome was that the toolkit would increase cervical cancer screenings 
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rates at CCHS and increase staff and patient knowledge of cervical cancer screening guidelines. 
Based on the evaluation data, these outcomes were all achieved, indicating that implementation 
of the toolkit was successful.  
There was an increase in the total number of screenings from 2015 to 2016; however, 
there were only 13 more screenings completed in 2016 following implementation of the toolkit 
when compared to the same time period the previous year. There were also fewer screenings 
done in October 2016 when compared to October 2015. One possible reason for this is that the 
provider group in 2015 was not the same as the provider group in 2016. It is also possible that 
there were less screenings in October 2016 because the information about PRIME and screening 
guidelines was not as fresh in the minds of staff as it was immediately following the 
presentation. It may have been beneficial to do a short follow up at the September or October 
meeting to remind staff of the tools available and give an update on the PRIME initiative.  
The PHCS pilot of the toolkit provided a lot of information about the current level of 
knowledge among staff and patients. The results indicate that staff and patients both need 
education about cervical cancer screening and that the toolkit components can help increase 
knowledge. This supports further dissemination of the toolkit for all providers and clinics.  It 
would also be beneficial to include the PowerPoint and toolkit components when onboarding 
new staff members. The PRIME Cancer Screening team can utilize the toolkit for yearly reviews 
of the guidelines and the current screening rates in CCHS. This would help reinforce knowledge 
of cervical cancer screening and remind staff about the goals of the PRIME program and the 
importance of adequately screening CCHS patients.  
The cervical cancer screening toolkit pilot validates that each component has the potential 
to increase cervical cancer screening rates in CCHS and improve staff and patient knowledge of 
INCREASING CERVICAL CANCER SCREENING RATES 42 
cervical cancer. The best way to disseminate the toolkit and sustain it would be to load it onto the 
eLearning system. If this happens, the educational module for providers, RNs, and CHWs could 
be tailored to the specific learning needs of each role. The toolkit will need to be updated and 
required for review by new hires and annually or as needed for guideline updates. There is also 
an opportunity to further support the PRIME Cancer Screening program by creating toolkits for 
colorectal and breast cancer screening.  
Conclusions 
Cervical cancer screening is essential for early detection and initiation of treatment before 
it progresses. CCHS relies heavily on federal and state funding in order to provide services like 
cancer screenings for the population of CCC. In order to receive funding from the new Medi-Cal 
2020 PRIME program, it was imperative that CCHS undertake projects that would lead to 
increased cervical cancer screening rates. The implementation of the educational evidence-based 
toolkit that educates staff and patients demonstrated that it can help effectively help increase 
cervical cancer screening for CCHS. The toolkit can be modified to include the latest evidence in 
order to ensure that CCHS patients are receiving the healthcare services they need in a timely 
manner. Similar to previous research demonstrating the effectiveness of using an educational 
toolkit, the cervical cancer screening toolkit was an effective way to aid in the effort to increase 
cervical cancer screening rates for CCHS.  
Funding 
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compensation for time spent planning, implementing, or evaluating the project.  
  
INCREASING CERVICAL CANCER SCREENING RATES 43 
References 
American College of Obstetricians and Gynecologists (2015). Frequently Asked Questions: 
FAQ163 gynecologic problems. Retrieved from 
http://www.acog.org/~/media/For%20Patients/faq163.pdf. 
American Nurses Association (2016). Code of ethics for nurses with interpretive statements. 
Retrieved from http://nursingworld.org/DocumentVault/Ethics-1/Code-of-Ethics-for-
Nurses.html. 
Bernard, V. B., Thomas, C. C., King, J., Massetti, G. M., Doria-Rose, V. P., & Saraiya, M. 
(2014). Vital signs: Cerivcal cancer incidence, mortality, and screening –United States, 
2007-2012. Morbidity and Mortality Weekly Report, 63(44), 1004-1009.  
Brown, D. R., Wilson R. M., Boothe, M. A., & Harris, C. E. S. (2011). Cervical cancer screening 
among ethnically diverse black women: Knowledge, attitudes, beliefs, and practices. 
Journal of the National Medical Association, 103(8), 719–728. doi:10.1016/S0027-
9684(15)30411-9. 
California Department of Health Care Services (2016a). Center for Medicare & Medicaid 
Special Terms and Conditions. Retrieved from 
http://www.dhcs.ca.gov/provgovpart/Documents/MC2020_FINAL_STC_12-30-15.pdf. 
California Department of Health Care Services (2016b). Medi-Cal waivers. Retrieved from 
http://www.dhcs.ca.gov/services/medi-cal/Pages/MediCalWaivers.aspx. 
California Department of Health Care Services (2016c). Attachment Q- PRIME projects and 
metrics protocol. Retrieved from 
http://www.dhcs.ca.gov/provgovpart/Documents/MC2020_AttachmentQ_PRIMEProject
sMetrics.pdf.  
INCREASING CERVICAL CANCER SCREENING RATES 44 
Center for Disease Control (2014). Cancer screening in the United States. Retrieved from 
http://www.cdc.gov/cancer/dcpc/research/articles/screening_us.htm. 
Chase, D. M., Watanabe, T., & Monk, B. J. (2010). Assessment and significance of quality of 
life in women with gynecologic cancer. Future Oncology 6(8), 1279-1287. 
Contra Costa Health Services (2016a). Cervical cancer screening rate (family med) [ccLink 
report]. Martinez, CA: Contra Costa Health Services. 
Contra Costa Health Services (2016b). About us. Retrieved from 
http://cchealth.org/healthservices/.  
Corbelli, J., Borrero, S., Bonnema, R., McNamara, M., Kraemer, K., Rubio, D., …, McNeil, M. 
(2014). Differences among primary care physicians’ adherence to 2009 ACOG 
guidelines for cervical cancer screening. Journal of Women’s Health, 23(5), 397-403. 
doi: 10.1089/jwh.2013.4475. 
Flores, B. E., & Acton, G. J. (2013). Older Hispanic women, health literacy, and cervical cancer 
screening. Clinical Nursing Research, 22(4), 402-415. doi: 10.1177/1054773813489309. 
Freed G. L., Pathman, D. E., Konrad, T. R., Freeman, V. A., Clark, S. J. (1998). Adopting 
immunization recommendations: A new dissemination model. Maternal and Child 
Health Journal, 2(4), 231-239. doi: 1092-7875/98/1200-231$15.00/0. 
Han, P. K. J., Klabunde, C. N., Breen, N., Yuan, G., Grauman, A., Davis, W. W., Taplin, S. H. 
(2011). Multiple clinical practice guidelines for breast and cervical cancer screening: 
Perceptions of US primary care physicians.  Medical Care, 49(2): 139-148. 
doi:10.1097/MLR.0b013e318202858e. 
Kaczorowski, J., Hearps, S. J.C., Lohfeld, L., Goeree, R., Donald, F., Burgess, K., & Sebaldt, R. 
J. (2013). Effect of provider and patient reminders, deployment of nurse practitioners, 
INCREASING CERVICAL CANCER SCREENING RATES 45 
and financial incentives on cervical and breast cancer screening rates. Canadian Family 
Physician, 59(6), e282-e289.  
Moyer, V. A. (2012). Clinical guideline: Screening for cervical cancer: U.S. preventive services 
task force recommendation statement. Annals of Internal Medicine, 156(12), 880-891.  
Nardi, C., Sandhu, P., & Selix, N. (2016). Cervical cancer screening among minorities in the 
United States. The Journal for Nurse Practitioners, 12(10), 675-682.  
National Cancer Institute (2016).  Surveillance epidemiology and end results stat fact sheets: 
Cervix uteri cancer. Retrieved from http://seer.cancer.gov/statfacts/html/cervix.html. 
National Cancer Institute (2015). Financial burden of cancer care. Retrieved from 
http://progressreport.cancer.gov/after/economic_burden. 
Nolan, J., Renderos, T. B., J., Xue Dai, X., Chow, W., Christie, A., & Mangione, T. W.  (2014). 
Barriers to cervical cancer screening and follow-up care among black women in 
Massachusetts. Journal of Obstetrics, Gynecologic, & Neonatal Nursing, 43(5), 580-588.    
Pathman, D. E., Konrad, T. R., Freed G. L., Freeman, V. A., & Koch, G. G. (1996). The 
awareness-to-adherence model of the steps to clinical guideline compliance: the case of 
pediatric vaccine recommendations. Medical Care, 34(9), 873-889. 
http://www.jstor.org/stable/3766709. 
Sabatino, S. A., White, M. C., Thompson, T. D., & Klabunde, C. N. (2015). Cancer screening 
test use—United States, 2013. Morbidity and Mortality Weekly Report, 64(17), 464-468. 
Schwaiger, C. B., Aruda, M. M., LaCoursiere, S., Lynch, K. E., & Rubin, R. J. (2013). 
Increasing adherence to cervical cancer screening guidelines. The Journal for Nurse 
Practitioners, 9(8), 528-535. http://dx.doi.org/10.1016/j.nurpra.2013.05.013. 
Sharma, M. (2017). The health belief model. In Theoretical foundations of health education and 
INCREASING CERVICAL CANCER SCREENING RATES 46 
health promotion (3rd. ed). Burlington, MA: Jones & Bartlett Learning. 59-76.  
Spundak, M. (2014). Mixed agile/traditional project management methodology—reality or 
illusion?. Procedia—Social and Behavioral Sciences, 119(2014), 939-948. 
Teoh, D. G., Marriott, A. E., Vogel, R. I., Marriott, R. T., Lais, C. W., Downs Jr, L. S., & 
Kulasingam, S. L. (2015). Adherence to the 2012 national cervical cancer screening 
guidelines: A pilot study. American Journal of Obstetrics and Gynecology, 212(#), 62.e1-
9.  
Vesco, K. K., Whitlock, E. P., Eder, M., Lin, J., Burda, B. U., Senger, C. A.,…Zuber, S. (2011). 
Screening for cervical cancer: a systematic evidence review for the U.S. Preventive 
Services Task Force. Evidence Synthesis No. 86. Agency for Healthcare Research and 
Quality (Publication No. 11-05156-EF-1). Retrieved from 
http://www.ncbi.nlm.nih.gov/books/NBK66099/. 
University of Missouri Department of Family & Community Medicine (2014). Cervical Cancer 
Screening. Retrieved from http://fcm-
algo.umh.edu/Algorithms/CervicalCancerScreening/CervicalCancerScreening.htm 
U.S. Department of Health and Human Services, Office of Disease Prevention and Health 
Promotion (2016). Healthy People 2020 Topics and Objectives: Cancer. Retrieved from 
http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=5.  
Walker, W. B. (2016). What’s ahead in 2016. Contra Costa Health Services Director’s Report. 
Retrieved from http://cchealth.org/healthservices/pdf/directors-report-2016-02.pdf.   
Warren, D. M., & Thomas, E. (2011). The relationship between limited English proficiency and 
cervical cancer screening in Hispanic women. Women’s Health Care, 10(9), 31-35. 
  
INCREASING CERVICAL CANCER SCREENING RATES 47 
Appendix A 
PRIME Program Goals 
 
 (California Department of Health Care Services, 2016a) 
  
PRIME
1.	Increasing	capabilities	to	
furnish	patient-centered,	
data-drive,	team-based	
care	to	Medi-Cal	
beneficiairies,	especially	
high	utlizers	or	those	at	risk	
of	becoming	high	utilizers.	
2. Improving	the	capacity	
to	provide	point- of-care	
services,	complex	care	
management,	and	popu-
lation	health	management	
by	strengthening	data	
analytic	capacity	to	drive	
system-level	improvement	
and	culturally	competent	
care
3.	Improve	population	
health	and	health	
outcomes	as	evidenced	by	
the	achievement	of	
performance	goals	related	
to	clinical	improvements,	
effective	preventive	
interventions,	and	
improved	patient	
experience	metrics
4.	Improving	the	ability	to	
furnish,	in	the	most	
appropriate	setting,	high-
quality,	care	that	integrates	
physical	and	behavioral	
health	services	and	
coordinates	care	in	
different	settings	for	
targeted	vulnerable	Medi-
Cal	beneficiaries	
5.	Moving	participating	
PRIME	entities	towards	
value-based	payments	
through	the	adoption	of	
alternative	payment	
models
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Appendix B 
PRIME Program Domains 
 
(California Department of Health Care Services, 2016a) 
 
•Projects	that	will	ensure	that	patients	experience	timely	access	
to	high-quality,	efficient,	and	patient-centered care
•Patients	will	receive	appropriate	preventive	services,	early	
diagnosis	and	treatment,	and	will	be	supported	in	improving	
their	ability	to	care	for	themselves
•Identify	and	increase	rates	of	cost-effective	standard	
approaches	to	prevention	services	for	a	select	group	of	high	
impact	clinical	conditions	and	populations	(cardiovascular	
disease,	breast,	cervical	and	colorectal	cancer,	and	obesity)				
Domain	1:
Projects	that	will	
ensure	that	
patients	
experience	timely	
access	to	high-
quality,	efficient,	
and	patient-
centered	care	
•Projects	focused	on	specific	populations	that	would	benefit	
most	significantly	from	care	integration	and	alignment	
•Attention	will	be	focused	on	managing	and	coordinating	care	
during	transitions	from	inpatient	to	outpatient	and	post-acute	
settings,	to	optimize	the	care	experience	and	outcomes	
•Improved	Perinatal	Care,	Care	Transitions:	Integration	of	Post-
Acute	Care	and	Complex	Care	Management	for	High	Risk	
Medical	Populations	
Domain	2:	
Targeted	High-
Risk	or	High-Cost	
Populations.	
• Projects	that	will	reduce	unwarranted	variation	in	the	use	
of	evidence-based,	diagnostics	and	treatments	
(antibiotics,	blood	or	blood	products,	and	high	cost	
imaging	studies	and	pharmaceutical	therapies)	targeting	
overuse,	misuse,	as	well	as	inappropriate	underuse	of	
effective	interventions.	
• Projects	will	also	eliminate	the	use	of	ineffective	or	
harmful	targeted	clinical	services	
Domain	3:	
Resource	
Utilization	
Efficiency.	
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Appendix C 
Letter of Support from Contra Costa Health Services
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Appendix D 
Johns Hopkins Nursing Evidence-based Practice Rating Scale 
 
  
JHNEBP EVIDENCE RATING SCALES 
 ©  The Johns Hopkins Hospital/The Johns Hopkins University 
STRENGTH of the Evidence 
Level I   Experimental study/randomized controlled trial (RCT) or meta analysis of RCT
Level II Quasi-experimental study
Level III Non-experimental study, qualitative study, or meta-synthesis.
Level IV Opinion of nationally recognized experts based on research evidence or expert 
consensus panel (systematic review, clinical practice guidelines)
Level V Opinion of individual expert based on non-research evidence. (Includes case 
studies; literature review; organizational experience e.g., quality improvement 
and financial data; clinical expertise, or  personal experience) 
     
QUALITY of the Evidence 
A   High   
 
Research consistent results with sufficient sample size, adequate control, and definitive conclusions; consistent 
recommendations based on extensive literature review that includes thoughtful reference to scientific 
evidence. 
Summative 
reviews  
well-defined, reproducible search strategies; consistent results with sufficient numbers of well defined 
studies; criteria-based evaluation of overall scientific strength and quality of included studies; definitive 
conclusions. 
Organizational well-defined methods using a rigorous approach; consistent results with sufficient sample size; use of 
reliable and valid measures 
Expert Opinion expertise is clearly evident 
B   Good Research reasonably consistent results, sufficient sample size, some control, with fairly definitive conclusions; 
reasonably consistent recommendations based on fairly comprehensive literature review that includes some 
reference to scientific evidence 
Summative 
reviews  
reasonably thorough and appropriate search; reasonably consistent results with sufficient numbers of well 
defined studies; evaluation of strengths and limitations of included studies; fairly definitive conclusions. 
Organizational Well-defined methods; reasonably consistent results with sufficient numbers; use of reliable and valid 
measures; reasonably consistent recommendations 
Expert Opinion expertise appears to be credible. 
C   Low quality 
or major 
flaws 
Research little evidence with inconsistent results, insufficient sample size, conclusions cannot be drawn 
Summative 
reviews  
undefined, poorly defined, or limited search strategies; insufficient evidence with inconsistent results; 
conclusions cannot be drawn 
Organizational Undefined, or poorly defined methods; insufficient sample size; inconsistent results; undefined, poorly 
defined or measures that lack adequate reliability or validity 
Expert Opinion expertise is not discernable or is dubious. 
*A study rated an A would be of high quality, whereas, a study rated a C would have major flaws that raise serious questions about the 
believability of the findings and should be automatically eliminated from consideration. 
 
 
Newhouse R, Dearholt S, Poe S, Pugh LC, White K. The Johns Hopkins Nursing Evidence-based Practice Rating Scale.  2005. Baltimore, MD, 
The Johns Hopkins Hospital; Johns Hopkins University School of Nursing.  
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Appendix E 
Literature Review 
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Appendix F 
Awareness-to-Adherence Model  
 
 
(Pathman et al., 1996) 
 
  
Preawareness
Awareness
Agreement
Adoption
Adherence
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Appendix G 
Health Belief Model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Sharma, 2016)  
Perceived	
Susceptibility
Perceived	
Severity
Perceived	
Benefits
Pervceived	
Barriers
Cues	to	Action
Self-Efficacy
Health	
Behavior	
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Appendix H 
Kurt Lewin’s Model of Change 
 
(Mullins, 2013) 
  
•Ensure	
readiness	for	
change
Unfreeze
•Execute	the	
intended	
change
Change •Enusres	that	the	
change	
becomes	
permanent
Refreeze
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Appendix I 
Statement of Determination 
 
DNP Project Approval Form: Statement of Determination 
Student Name:__Christina Nardi_______________________ 
Title of Project: Using multi-modal education in a Public Health System, to increase rates of 
Cervical Cancer screening 
Brief Description of Project:  
A) Aim Statement: This project will promote Increased rates of cervical cancer screening over a 
3-month period through an evidence-based educational cervical cancer screening toolkit at 
Contra Costa Health Services (CCHS). 
 
B) Description of Intervention: Creation and implementation of an evidence-based educational 
cervical cancer screening toolkit for providers and patients. The toolkit will include an eLearning 
educational module for providers (physicians and Advanced Practice Providers), nurses, and 
medical assistants about the cervical cancer screening guidelines, the algorithm for cervical 
cancer screening according to the most current guidelines, and a handout for patients about 
cervical cancer screening. The eLearning module will be piloted with the Public Health Clinic 
Services group in person, during the monthly meeting. Following the pilot, the PRIME Cancer 
Screening team will decide if any changes need to be made before loading it as and eLearning 
module for all CCHS Clinical Services care team members.   
 
C) How will this intervention change practice? The current cervical cancer screening rates in 
the CCHS are below the standard of 60%. The goal is that providers will screen a minimum of 
60% of their patient panel that are supposed to be screened according to the current guidelines. 
The median screening rate for providers is currently 40%. Research shows that adequate cervical 
cancer screening is essential to preventing death as it can be treatable if detected early enough. 
Research also indicates that patient/provider collaboration can increase screening rates. The 
toolkit will help educate providers and patients in order to increase knowledge about cervical 
cancer screening and make the patients more informed so they can be more proactive in getting 
appropriate screenings done. This should lead to an increase cervical cancer screening rates.  
 
D) Outcome measurements:    
1. PHCS Cervical cancer screening rates pre and post implementation of the toolkit. 
2. Assessment of PHCS staff knowledge of cervical cancer screening guidelines pre and post 
implementation of the toolkit.  
3. Assessment of patient knowledge of cervical cancer screening guidelines, pre and post 
implementation of the toolkit.   
 
To qualify as an Evidence-based Change in Practice Project, rather than a Research Project, the 
criteria outlined in federal guidelines will be used: (http://answers.hhs.gov/ohrp/categories/1569)  
 This project meets the guidelines for an Evidence-based Change in Practice Project as 
outlined in the Project Checklist (attached). Student may proceed with implementation.  
This project involves research with human subjects and must be submitted for IRB approval 
before project activity can commence. Comments:  
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Appendix J 
Cervical Cancer Screening PowerPoint 
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1
Cervical Cancer 
Screening
Improving rates in CCHS
Objectives
• Understand the Medi-Cal 2020 PRIME Program
• Review of the current cervical cancer screening rates for 
CCHS
• Learn the target screening rate required to meet the 
PRIME benchmark
• Understand the current screening methods and 
guidelines for cervical cancer screening 
• Cervical cancer screening follow up recommendations
• Your role in promoting screening
PRIME Program
Public Health Incentives and Redesign in Medi-Cal
PRIME Program
• Contra Costa County receives 87% of funding from federal 
and state funding programs.1
• The California Department of Health Care Services 
(DHCS) helps fund health care services for about 13.3 
million Medi-Cal members.2
• Medi-Cal waivers are DHCS programs that provide 
services for individuals who may not be eligible under 
Medicaid rules.3
• The DHCS recently renewed the 5-year Medi-Cal 1115 
waiver for 2016 to 2020, which is called Medi-Cal 2020. 
(Cont.)
PRIME Program cont.
• Medi-Cal 2020 has four new programs aimed at improving 
care. One program is the 5-year Public Health Incentives 
and Redesign in Medi-Cal (PRIME) program. 
• PRIME funds will be used to compensate CCHS and other 
similar safety-net systems for showing improvements in 
ambulatory care.4
• PRIME has fivemain goals and every Designated Public 
Hospital (DPH) wishing to receive funds must complete 
projects within each of three domains and achieve specified 
benchmarks.2,4
(Cont.)
PRIME Goals
1. Increasing capabilities to furnish patient-centered, 
data-drive, team-based care to Medi-Cal beneficiaries, 
especially high utilizers or those at risk of becoming high 
utilizers. 
2. Improving the capacity to provide point- of-care 
services, complex care management, and population 
health management by strengthening data analytic 
capacity to drive system-level improvement and culturally 
competent care
(Cont.)
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3. Improve population health and health outcomes as 
evidenced by the achievement of performance goals 
related to clinical improvements, effective preventive 
interventions, and improved patient experience metrics
4. Improving the ability to furnish, in the most 
appropriate setting, high-quality, care that integrates 
physical and behavioral health services and coordinates 
care in different settings for targeted vulnerable Medi-Cal 
beneficiaries 
5. Moving participating PRIME entities towards value-
based payments through the adoption of alternative 
payment models.2
Three PRIME Domains
1. Projects that will ensure that patients 
experience timely access to high- quality, 
efficient, and patient-centered care 
2. Targeted High-Risk or High-Cost Populations. 
3. Resource Utilization Efficiency.2
•Projects that will ensure patients 
experience timely access to high- quality, 
efficient, and patient-centered care.
•Patients will receive appropriate 
preventive services, early diagnosis and 
treatment, and will be supported in 
improving their ability to care for 
themselves.
•Identify and increase rates of cost-
effective standard approaches to 
prevention services for a select group of 
high impact clinical conditions and 
populations (cardiovascular disease, 
breast, cervical and colorectal cancer, and 
obesity).    
Domain 1:
Projects that 
will ensure that 
patients 
experience 
timely access to 
high-quality, 
efficient, and 
patient-
centered care. 
•Projects focused on specific populations 
that would benefit most significantly 
from care integration and alignment 
•Attention will be focused on managing 
and coordinating care during transitions 
from inpatient to outpatient and post-
acute settings, to optimize the care 
experience and outcomes 
•Improved Perinatal Care, Care 
Transitions: Integration of Post-Acute 
Care and Complex Care Management for 
High Risk Medical Populations 
Domain 2: 
Targeted 
High-Risk or 
High-Cost 
Populations. 
•Projects that will reduce unwarranted 
variation in the use of evidence-based, 
diagnostics and treatments (antibiotics, 
blood or blood products, and high cost 
imaging studies and pharmaceutical 
therapies) targeting overuse, misuse, as 
well as inappropriate underuse of effective 
interventions. 
•Projects will also eliminate the use of 
ineffective or harmful targeted clinical 
services 
Domain 3: 
Resource 
Utilization 
Efficiency. 
PRIME and Cancer Screening
Ø Increasing Contra Costa Health Services 
cervical cancer screening rates meets Goal 3 
and Domain 1 of the PRIME Program.
Ø Continued funding from Medi-Cal 2020 
waiver is crucial for CCHS to continue 
providing high-quality services. 
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Cervical Cancer
Incidence and Mortality
• In 1975, the incidence of new cases of cervical 
cancer was 14.8 per 100,000 persons. 
• 2013: 6.4 per 100,000 persons
• 2016: estimated 12,990 new cases and 4, 120 
deaths
• 5-year survival rate if it is localized when 
diagnosed is 91.3%, 57.4% if it is regional, and 
16.8% if it is distant.7
Screening Rates
Current Rate PRIME Benchmark
Target Goal
Screening Tests
Papanicolau (Pap) Test
• SurePath for cytology
Screening Tests
HPV Test
• ThinPrep for HPV co-testing
• Never screen with HPV testing 
alone
Screening Guidelines
United States Preventive Services Task Force 2012 Recommendations8
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Screening Guidelines Screening Guidelines
HPV testing is not recommended in 
this age group. 
Screening Guidelines Screening Guidelines
Screening Considerations
Age Over 65
•Adequate prior screening
 3 consecutive negative cytology results or 
 2 consecutive negative HPV results within 10 
years before cessation of screening, with the most 
recent test occurring within 5 years.
Screening Considerations
Age Over 65
•High risk for cervical cancer
 HPV infection
 HIV infection
 Compromised immune system
 In utero exposure to diethylstilbestrol
 History high grade precancerous lesion or cervical 
cancer
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Screening Considerations
Age Over 65
•Routine screening should continue for at 
least 20 years after spontaneous regression 
or appropriate management of a high-grade 
precancerous lesion, even if this extends 
screening past age 65 years
Screening Guidelines
Special Populations
• HIV positive
• organ transplantation
• chemotherapy
• chronic steroid therapy 
Special Populations
Follow-Up
How to manage abnormal Pap test results9
Management of 
Abnormal Pap 
Smear
Age 21-24 years old
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Management 
of Abnormal 
Pap Smear
Age > 25 years old
What does this mean for you?
Your role in promoting cervical cancer screening
CHWs
•Review health 
maintenance before 
the visit
 When is the patient’s 
next Pap due?
 Are they due at this 
visit?
Health Maintenance Review
Don’t just rely on the dates you see
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Providers
• Is the patient due for screening today?
• What are you screening for?
• How is it done?
Follow-Up
How to manage abnormal Pap test results9
Management of 
Abnormal Pap 
Smear
Age 21-24 years old
Management 
of Abnormal 
Pap Smear
Age > 25 years old
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Additional Health Maintenance
• For women > 50 years 
old, who have not had a 
colonoscopy
• For women age 50-74 
years old who have not 
had a mammogram
References
1. Contra Costa Health Services (2016). About us. Retrieved from http://cchealth.org/healthservices/.
2. California Department of Health Care Services (2016a). Center for Medicare & Medicaid Special Terms and 
Conditions. Retrieved from http://www.dhcs.ca.gov/provgovpart/Documents/MC2020_FINAL_STC_12-30-15.pdf
3. California Department of Health Care Services (2016b). Medi-Cal waivers. Retrieved from 
http://www.dhcs.ca.gov/services/medi-cal/Pages/MediCalWaivers.aspx
4. Walker, W. B. (2016). What ’s ahead in 2016. Contra Costa Health Services Director’s Report. Retrieved from 
http://cchealth.org/healthservices/pdf/directors-report-2016-02.pdf.
5. U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion (2014). 
About Healthy People. Retrieved from https://www.healthypeople.gov/2020/About-Healthy-People 
6. U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion (2016). 
Healthy People 2020 Topics and Objectives: Cancer. Retrieved from http://www.healthypeople.gov/2020/topicsobject ives2020/object iveslist .aspx?topicId=5. 
7. National Cancer Institute (2016, April 1). Surveillance epidemiology and end results stat fact sheets: Cervix uteri 
cancer. Retrieved from http://seer.cancer.gov/statfacts/html/cervix.html.
8. Moyer, V. A. (2012). Clinical guideline: Screening for cervical cancer: U.S. preventive services task force recommendation statement. Annals of Internal Medicine, 156(12), 880-891. 
9. University of Missouri Department of Family & Community Medicine (2014). Cervical Cancer Screening. Retrieved from http://fcm-algo.umh.edu/Algorithms/CervicalCancerScreening/CervicalCancerScreening.htm
INCREASING CERVICAL CANCER SCREENING RATES 67 
Appendix K 
Pocket Guide 
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Population Recommendation 
Women 
< 21 years Screening is not recommended. 
Women 
21 to 29 
years 
Screening with cytology only every 3 years. 
HPV screening is not recommended, alone or 
with cytology. 
Women 
30 to 65 
years 
Cytology (Pap smear) in combination with HPV 
testing every 5 years or with cytology alone 
every 3 years. 
Women 
> 65 years 
Screening is not recommended if prior adequate 
screeninga and are not considered high risk for 
cervical cancerb. 
Women who 
have had a 
hysterectomy 
Screening not recommended in women who 
have had hysterectomy with the cervix removed 
and no history of high-grade precancerous 
lesion (CIN 2 or 3) or cervical cancer. 
2012 USPSTF 
Cervical Cancer Screening Guidelines* 
*Does not apply to women who have received a diagnosis of a high-grade 
precancerous cervical lesion or cervical cancer, women with in utero exposure 
to diethylstilbestrol, or women who are immunocompromised (HIV positive, 
organ transplantation, chemotherapy, chronic steroid therapy).	
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a Adequate prior screening is defined as: 
• 3 consecutive negative cytology results or 2 consecutive 
negative HPV results within 10 years before cessation of 
screening, with the most recent test occurring within 5 years. 
•  Routine screening should continue for at least 20 years after 
spontaneous regression or appropriate management of a 
high-grade precancerous lesion, even if this extends 
screening past age 65 years. 
 
b High Risk for Cervical Cancer: 
• HPV infection 
• HIV infection 
• Compromised immune system  
• In utero exposure to diethylstilbestrol (DES) 
• History high grade precancerous lesion or cervical cancer 
	
	
Population Recommendation 
Immunocompromised 
women 
Cytology screening twice (every 6 
months) within the first year of 
diagnosis. If both tests are normal, 
resume annual screening. 
Pregnant women Screening with same frequency as nonpregnant women.  
Screening Considerations 
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Management of Abnormal Results  
21-24 years old 
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Post-Colposcopy	Follow-Up	
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Post-Colposcopy	Follow-Up	
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Management of Abnormal Results  
25 years or older 
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Post-Colposcopy	Follow-Up	
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Post-Colposcopy	Follow-Up	
(University	of	Missouri	Department	of	Family	&	Community	Medicine,	2014)	(University	of	Missouri	Department	of	Family	&	Community	Medicine,	2014)	
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Patient Handout 
 
Prevent	Cervical	Cancer	
It’s	time	to	get	screened	
Don’t	wait	until	it’s	too	late!	Call	to	schedule	your	Pap	test	
Appointment	Unit:	1-800-495-8885	
Financial	Counselor:	1-800-771-4270	
	
Your	Pap	test	appointment	is	scheduled	on:	____________	
When	to	get	screened	
Most	women	don’t	need	yearly	Pap	tests!	
• Get	your	first	Pap	test	at	age	21	
• If	your	results	are	normal,	you	don’t	need	to	
be	screened	again	for	3	years.	
• When	you	turn	30	and	if	your	results	are	
normal,	you	can	get	screened	with	a	Pap	test	
and	HPV	test	every	5	years.	
• You	can	stop	getting	screened	if:	
	
	
	
	
ü You	are	older	
than	65	and	have	
had	normal	Pap	
test	results.	
ü You	do	not	need	to	be	
screened	if	your	cervix	
was	removed	during	a	
surgery	for	a	non-
cancerous	condition.	
The	cervix	is	the	lower,	narrow	end	
of	the	uterus	that	connects	the	
uterus	to	the	vagina.	
Cervical	Cancer	is	the	abnormal	growth	of	cells	that	starts	in	the	cervix.	It	can	
spread	to	other	parts	of	the	body	if	it	is	not	treated.	There	may	not	be	any	signs	
or	symptoms	early	on.	It	is	important	to	get	screened	to	detect	cervical	cancer.	
Screening	
• When	cervical	cancer	is	found	early,	it	is	very	
treatable	and	increases	the	chance	of	survival.	
• There	are	two	tests	that	screen	for	cervical	cancer	
ü The	Pap	test	looks	for	changes	in	the	cells	of	the	
cervix.	These	changes	can	lead	to	cervical	
cancer	if	left	untreated.	
ü The	human	papillomavirus	(HPV)	test	looks	for	
the	virus	that	can	cause	cell	changes.	
	
	
HPV	
• HPV	is	a	virus	that	is	the	main	
cause	of	cervical	cancer.	
• It	is	a	common	virus	passed	
from	one	person	to	another	
during	sex.		
• Most	people	get	it,	but	it	
typically	goes	away	without	
treatment.	
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Patient Handout in Spanish 
 
  
Prevenga	el	cáncer	de	cuello	uterino		
Es	el	momento	de	hacerse	las	pruebas			
No espere hasta que sea demasiado tarde! Llame para 
programar su prueba de Papanicolaou 
Unidad	de	citas:	1-800-495-8885	
Asesero	financiero:	1-800-771-4270	
	
Su cita para Papanicolaou es:	____________	
Cuándo	hacerse	pruebas		
La	mayoría	de	las	mujeres	no	necesitan	hacerse	pruebas	
de	Papanicolau	todos	los	anos!	
• Hágase	esta	prueba	por	primera	vez	cuando	tenga	
21	años	
• Si	los	resultados	de	su	prueba	son	normales,	puede	
esperar	3	años	antes	de	hacerse	la	próxima	prueba	
de	Papanicoláu.	
• Cuando	cumpla	30	años	y	si	los	resultados	de	sus	
pruebas	son	normales,	puede	hacerse	las	pruebas	de	
Papanicoláu	y	VPH	cada	5	años	
Puede	dejar	de	hacerse	pruebas	de	detección	en	los	
siguientes	casos	
	
	
	
ü Es	mayor	de	65	años	y	
ha	tenido	resultados	
normales	de	la	prueba	
de	Papanicoláu.	
ü Le	extirparon	el	cuello	
uterino	quirúrgicamente	
a	causa	de	una	afección	
no	cancerosa.	
El	cuello	uterino	es	el	extremo	inferior	
angosto	del	útero	que	conecta	el	útero	
con	la	vagina.	
El cáncer cervical es el crecimiento anormal de las células que se inicia en el cuello 
del útero. Se puede propagar a otras partes del cuerpo si no es tratada. Puede que no 
haya ningún signo o síntoma temprano. Es importante hacerse las pruebas para 
detectar el cáncer de cuello uterino.	
	
Las	Pruebas	
•	Cuando	se	detecta	el	cáncer	de	cuello	uterino	temprano,	es	
muy	tratable	y	aumenta	las	posibilidades	de	supervivencia.	
•	Existen	dos	exámenes	que	detectan	el	cáncer	de	cuello	de	
útero:	
ü La	prueba	de	Papanicolaou	busca	cambios	en	las	
células	del	cuello	uterino.	Estos	cambios	pueden	
conducir	al	cáncer	cervical	si	no	se	tratan.	
ü La	prueba	del	virus	del	papiloma	humano	(VPH)	busca	
el	virus	que	puede	causar	cambios	en	las	células.	
VPH	
• El	VPH	es	la	causa	principal	del	
cáncer	de	cuello	uterino.	
• El	VPH	es	un	virus	muy	común	
que	se	transmite	de	persona	a	
persona	durante	las	relaciones	
sexuales.		
• La	mayoria	de	las	personas	
contraen	este	virus,	pero	
generalmente	desaparece	solo.	
Ovario
s	
Trompas	de	falopio	
	
Útero	
	
Vagina	
	
Cuello	
Uterin
o	
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Cost Benefit Analysis 
  
COSTS
- Estimated	$1.5 billion	in	national	expenditures	
for	cervical	cancer	care
- Inital	care	costs:	$0.6	billion
- Continuing	care	costs:	$0.2	billion
- Final	care	costs:	$0.7	billion
- Lost	productivity due	to	cervical	cancer	deaths:	
$1.8	billion
BENEFITS	
- Potential	to	save	by	reducing	final	year	costs
- Screening	with	Pap test	and HPV costs	$200
- Improved	quality	of	life	with	early	detection
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Appendix O 
 
Communication Plan 
 
  
Author	
Christina	Nardi
DNP	Chair
Prabjot Sandhu
Weekly	email
In	person,	phone as	needed
Faculty Meeting
Monthly
Co-chair
Nancy	Selix
Monthly	or	as	needed
Contra	Costa	County	
Weekly,	in	person	or	
email
Public	Health	Clinic	
Services	Managers
Arlene	Lin
Michelle	Sharman
Weekly
PRIME	Screening Leader
Heather	Cedermaz
Bi-weekly	in	person,	by	e-
mail	as	needed
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Appendix P 
Pre-Assessment 
 
Role:         Provider            Nurse            CHW 
Cervical Cancer Screening Pre-Assessment 
 
Please rate on a scale of 1 to 5. 1-Strongly Disagree (SD), 2- Disagree D), 3- Neither agree or 
disagree (N) 4-Agree (A), 5- Strongly Agree (SA) 
 
 SD D N A SA 
1. I am confident in determining when the patient is 
due for cervical cancer screening. 
1 2 3 4 5 
2. I am confident in determining what test(s) the 
patient needs for cervical cancer screening. 
1 2 3 4 5 
3. I know the current cervical cancer screening 
guidelines. 
1 2 3 4 5 
4. I routinely advise the patient when their next 
cervical cancer screening is due. 
1 2 3 4 5 
5. A 20F comes to clinic requesting a Pap smear. She states that she is sexually active. 
Based on the patient’s history she should 
a. Get a Pap test today 
b. Get a Pap test and HPV (co-test) today 
c. Get a Pap test when she is 21 years old 
d. Get a Pap test and HPV (co-test) until she is 21 years old 
 
6. A 26F comes for Pap test. Her last Pap was normal 3 years ago. She should: 
a. Get a Pap test today. 
b. Get a Pap test and HPV (co-test) today. 
c. Get a Pap and HPV (co-test) in 1 year. 
 
7. A 45F comes to clinic for her Pap test. Her last Pap test was 3 years ago. She should 
a. Get a Pap test today 
b. Get a Pap test and HPV (co-test) today 
c. Get a Pap test and HPV (co-test) in 2 years 
d. A or B  
 
8. A 68F comes to clinic requesting a Pap test. She has a history of 5 negative Pap tests 
over the past 15 years. She should 
a. Get a Pap test today 
b. Get a Pap test and HPV (co-test) today 
c. Discontinue getting Pap tests 
 
9. A 50F comes to clinic requesting a Pap test. She had a hysterectomy with the cervix 
removed 2 years ago. No history of cervical cancer or dysplasia. She should 
a. Get a Pap test today 
b. Get a Pap test and HPV (co-test) today 
c. Discontinue getting Pap tests 
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Post-Assessment 
 
Role:         Provider            Nurse            CHW 
	
Cervical Cancer Screening Post-Assessment 
 
Please rate on a scale of 1 to 5. 1-Strongly Disagree (SD), 2- Disagree D), 3- Neither agree or 
disagree (N) 4-Agree (A), 5- Strongly Agree (SA) 
 
 SD D N A SA 
1. I am confident in determining when the patient is 
due for cervical cancer screening. 
1 2 3 4 5 
2. I am confident in determining what test(s) the 
patient needs for cervical cancer screening. 
1 2 3 4 5 
3. I know the current cervical cancer screening 
guidelines. 
1 2 3 4 5 
4. I routinely advise the patient when their next 
cervical cancer screening is due. 
1 2 3 4 5 
5. A 20F comes to clinic requesting a Pap smear. She states that she is sexually active. 
Based on the patient’s history she should 
a. Get a Pap test today 
b. Get a Pap test and HPV (co-test) today 
c. Get a Pap test when she is 21 years old 
d. Get a Pap test and HPV (co-test) when she is 21 years old 
 
6. A 26F comes for Pap test. Her last Pap was normal 3 years ago. She should: 
a. Get a Pap test today. 
b. Get a Pap test and HPV (co-test) today. 
c. Get a Pap and HPV (co-test) in 2 years. 
 
7. A 45F comes to clinic for her Pap test. Her last Pap test was 3 years ago. She should 
a. Get a Pap test today 
b. Get a Pap test and HPV (co-test) today 
c. Get a Pap test and HPV (co-test) in 2 years 
d. A or B  
 
8. A 68F comes to clinic requesting a Pap test. She has a history of 5 negative Pap tests 
over the past 15 years. She should 
a. Get a Pap test today 
b. Get a Pap test and HPV (co-test) today 
c. Discontinue getting Pap tests 
 
9. A 50F comes to clinic requesting a Pap test. She had a hysterectomy with the cervix 
removed 2 years ago. No history of cervical cancer or dysplasia. She should 
a. Get a Pap test today 
b. Get a Pap test and HPV (co-test) today 
c. Discontinue getting Pap tests 
(Turn Over) 
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Evaluation 
 
 SD D N A SA 
1. I found the presentation useful for my practice. 1 2 3 4 5 
2. The presentation increased my understanding of 
cervical cancer screening guidelines. 
1 2 3 4 5 
3. I am more likely to advise patients when their 
next cervical cancer screening is due. 
1 2 3 4 5 
4. Annual guideline reviews would be helpful. 1 2 3 4 5 
5. I think patient education materials would be 
helpful for increasing screening rates. 
1 2 3 4 5 
 
 
Comments: 
 
INCREASING CERVICAL CANCER SCREENING RATES 83 
Appendix R 
Work Breakdown Structure 
 
 
  
Cervical	Cancer	
Screening	Toolkit
Initiation
Literature	Review
Form	DNP	committee
Submit	Statement	of	
Determination for	
Approval
Milestone:	Statement	
of	Determination	
approved
Planning
Evaluation	of	
evidence
Develop	project	plan
Submit	project	plan	
to	committee
Present	project	to	
stakeholders
Milestone:	approval	
of	project	plan	from	
DNP	committee	and	
stakeholder
Creation	of	toolkit:	
PowerPoint,	pocket	
guide,	patient	
handout
Milestone:	approval	
of	toolkit
Implementation
Present PowerPoint
Distribute	pocket	
guide	at	the	clinics
Distribute	patient	
handout	in	clinics
Milestone:	Toolkit	
completely	
distributed
Evaluation
Compare	pre- and	
post-toolkit	screening	
rates
Compare	pre- and	
post-test	data
Meeting	with	
stakeholders
Editing	toolkit	as	
needed	for	continued	
use
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GANTT Chart 
 2016 
Deliverable/Month Mar Apr May Jun July Aug Sep Oct Nov Dec 
Planning  
Selection of Topic                     
Review of the literature                     
Submit Statement of Determination                      
Formation of DNP Committee                     
Present project to DNP Committee                     
Develop goals and objectives                     
Formalize project with 
stakeholders, get letter of support                 
    
Creation of patient handout                      
Creation of PowerPoint and pocket 
guide                  
    
Creation of staff assessment survey                     
Implementation  
Presentation of PowerPoint                     
Evaluation  
Analysis of pre- and post-
PowerPoint assessments                     
Analysis of cervical cancer 
screening rates from September-
October 2015 
                    
Patient surveys regarding the 
patient handout                     
Analysis of cervical cancer 
screening rates from September-
October 2016 
                    
Presentation of findings to 
University                     
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Appendix T 
Budget 
Direct Expenses  Projected Expenses 
Actual 
Expenses 
 Hours   
DNP student (project manager) at 
$62.47/hr  135 hours $8,433.45 $8,433.45 
Stakeholder meeting time 
• Nurse Managers @ $58.24/hr 
• PRIME FNP Leader @ 
$58.64/hr 
 
10 hours 
5 hours 
 
$582.42 
$293.24 
 
$582.42 
$293.24 
Pocket guide 
• Printing  
50 guides 
$443.75 
10 guides 
$88.75 
Patient handout 
• Printing  
200 handouts 
$162.75 
50 handouts 
$40.69 
    
Staff completion of pre- & post-
toolkit assessments and PowerPoint at 
meeting 
• Family Nurse Practitioners* 
• Registered Nurses* 
• Community Health Workers 
(CHWs)* 
 
 
1.0 hour per FNP, 
RN, CHW 
 
 
20- $1,249. 40 
25- $1,169.50 
20- $412.60 
 
 
9- $562.23 
14- $654.92 
11- $226.93 
     
Estimated Total  $12,747.11 $10,882.73 
 
*The average hourly rate was used for the purposes of the proposed budget. Average hourly rate 
is $62.47/hr for FNPs, $46.78/hr for RNs, and $20.63/hr for CHWs 
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Patient Handout Assessment 
 
Cervical	Cancer	Screening	Pre	Assessment	
Age____________	
Primary	Language____________	
1. What	made	you	decide	to	make	an	appointment	today?	
	
	
2. Do	you	know	how	you	are	being	screened?	
	
	
3. Have	you	heard	of	HPV?	
	
	
4. Do	you	know	how	HPV	is	related	to	cervical	cancer?	
	
	
5. How	often	do	you	need	to	be	screened	with	a	Pap	test	only?	
	
	
6. How	often	do	you	need	to	be	screened	if	you	are	tested	with	a	Pap	and	HPV	test?	
	
	
7. If	you	don’t	have	abnormal	results,	at	what	age	can	you	stop	being	screened?	
	
Cervical	Cancer	Screening	Post	Assessment	
1. How	were	you	screened?	
	
	
2. How	is	HPV	related	to	cervical	cancer?	
	
	
3. How	often	do	you	need	to	be	screened	with	a	Pap	test	only?	
	
	
4. How	often	do	you	need	to	be	screened	if	you	are	tested	with	a	Pap	and	HPV	test?	
	
	
5. If	you	don’t	have	abnormal	results,	at	what	age	can	you	stop	being	screened?	
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SWOT Analysis 
Strengths Weaknesses 
Evidence supports the use of staff and patient 
education in order to increase screening rates 
 
Full support from stakeholders and the PRIME 
Cancer Screening team.  
 
Low cost of creating and implementing the 
toolkit.  
 
Ability to present to all staff at the monthly 
meeting.  
Unable to control how many staff members 
attend the meeting.  
 
Success of the toolkit requires buy-in from 
all staff members 
 
The initial implementation is only being 
piloted with the PHCS staff and not all of 
CCHS staff. 
 
Need for continued updating of the pocket 
reference.   
 
Only available to patients already in the 
clinic.  
Opportunities Threats 
Increased cervical cancer screening rates can 
improve health outcomes. 
 
Possibility of presenting at all CCHS health 
centers. 
 
Possibility of publishing the PowerPoint on an 
eLearning system with yearly reviews 
 
Obtaining funding from the Medi-Cal 2020 
waiver PRIME program.  
 
Future development of additional toolkit 
components for colorectal and breast cancer. 
The author will not be present following 
completion of the project to continue to 
update the guidelines. 
 
Lack of staff interest in the training.  
 
Possibility of staff not utilizing the toolkit 
components.  
 
All staff not completing the training and 
learning about the toolkit.   
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Comparison of PHCS Provider Screening Rates 
 
  
239
274275
251
220
230
240
250
260
270
280
September	 October
Cervical	Cancer	Screening	Rates	for
Public	Health	Clinic	Services	Providers
2015
2016
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Results of Pre and Post PowerPoint Staff Assessments  
On a scale of 1 to 5. 1-Strongly Disagree (SD), 2- Disagree (D), 3- Neither agree nor disagree 
(N) 4-Agree (A), 5- Strongly Agree (SA) 
 
74.07%
33.33% 37.04%
74.07%
85.19%88.24%
60.61%
29.41%
91.18%
97.06%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Scenario	Question	5 Scenario	Question6 Scenario	Question7 Scenario	Question	8 Scenario	Question	9
Questions	5-9
Cervical	Cancer	Screening	Scenarios
Pre-Assessment Post-Assessment
4.04 3.89
3.59
4
4.45 4.45 4.39 4.34
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
1.	I	am	confident	in	
determining	when	the	
patient	is	due	for	cervical	
cancer	screening.
2.	I	am	confident	in	
determining	what	test(s)	the	
patient	needs	for	cervical	
cancer	screening.
3.	I	know	the	current	
cervical	cancer	screening	
guidelines.
4.	I	routinely	advise	the	
patient	when	their	next	
cervical	cancer	screening	is	
due.
Questions	1-4
Staff	Rating	of	Cerivcal	Cancer	Screening	Practices
Pre-Assessment Post-Assessment
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Evaluation of PowerPoint Presentation 
Question Total Average Rating* 
1. I found the presentation useful for my practice. 4.68 
2. The presentation increased my understanding of cervical 
cancer screening guidelines. 4.64 
3. I am more likely to advise patients when their next cervical 
cancer screening is due. 4.63 
4. Annual guideline reviews would be helpful. 4.61 
5. I think patient education materials would be helpful for 
increasing screening rates. 4.76 
*On a scale of 1 to 5. 1-Strongly Disagree (SD), 2- Disagree (D), 3- Neither agree nor disagree 
(N) 4-Agree (A), 5- Strongly Agree (SA) 
 
 
*On a scale of 1 to 5. 1-Strongly Disagree (SD), 2- Disagree (D), 3- Neither agree nor disagree 
(N) 4-Agree (A), 5- Strongly Agree (SA) 
  
4.50
4.56
4.62
4.33
4.56
4.77
4.62
4.54
4.69
4.77
4.70 4.73 4.73 4.73
4.91
4.68
4.64 4.62 4.61
4.76
4
4.1
4.2
4.3
4.4
4.5
4.6
4.7
4.8
4.9
5
1.	I	found	the	
presentation	useful	for	
my	practice.
2.	The	presentation	
increased	my	
understanding	of	
cervical	cancer	
screening	guidelines.
3.	I	am	more	likely	to	
advise	patients	when	
their	next	cervical	
cancer	screening	is	
due.
4.	Annual	guideline	
reviews	would	be	
helpful.
5.	I	think	patient	
education	materials	
would	be	helpful	for	
increasing	screening	
rates.
Evaluation	of	PowerPoint	
Providers Nurses CHWs Total	Average
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Appendix Z 
Results of Patient Handout Pre and Post Assessments 
 
62.5%
37.5%
25.0%
0.0%
12.5%
62.5%
75.0% 75.0%
100.0%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Have	you	heard	of	
HPV?
How	is	HPV	related	to	
cervical	cancer?
How	often	do	you	
need	to	get	screened	
with	a	Pap	test	only?
How	often	do	you	
need	to	get	screened	
with	a	Pap	+	HPV	co-
test?
At	what	age	can	you	
discontinue	
screening?
Pre	and	Post	Handout	Patient	Assessment
Pre	Assessment Post	Assessment
